Submitted:
01 October 2024
Posted:
02 October 2024
You are already at the latest version
Abstract
The literature has addressed the negative impact of poor neonatal conditions (NC) across regions. This has drawn attention to the need to improve NC, particularly in Africa. NC research can make an important contribution. However, there is no study dedicated to this topic in Africa. Through a bibliometric analysis, we arrive at outputs that can inform scientists in planning ongoing or new NC research and those involved in developing and implementing strategies to combat poor NC. Using bibliometrics, the study identified the scientific knowledge on NC between 2000 and 2019, its visibility in the community, the main topics researched, and collaboration patterns.The results show that knowledge on NC has increased between 2000 and 2019, it is concentrated in a few African countries (Egypt, South Africa, Nigeria, Tanzania and Kenya), its visibility is below the world average, in general, maternal mortality is the most researched topic and collaborative activities are frequently, mainly international research collaboration (IRC), being the United States of America (USA) and the United Kingdom (UK) the main partners (they participated in 57% and 28% of all articles with IRC). The collaboration networks are fragile as 43%-67% of all links represent one article in 20 years.Ongoing or new research on NC in Africa should consider the main African players and their partners. There is a need to implement strategies to increase NC knowledge in other African countries, expand and strengthen the collaboration networks and diversify the sources of knowledge.
Keywords:
Africa
; health
; neonatal conditions
; bibliometrics
; collaboration
Introduction
In 2015, the United Nations General Assembly agreed on the 2030 Agenda for Sustainable Development. The agenda comprises 17 Sustainable Development Goals (SDGs) and 169 targets. The third SDG, Ensure healthy lives and promote well-being for all at all ages, is of great importance for Africa. The high burden of disease in Africa is responsible for high DALYs (a measure of the total burden of disease, expressed as the number of years lost due to illness, disability or early death) and consequently high GDP losses. A study looking at the productivity costs of disease in Africa estimates 629 603 271 DALYs in 2015, with NC responsible for 12% of those DALYs and an estimated productivity loss of Int$347 336 223 573 (International Dollars — a hypothetical unit of currency that has the same purchasing power parity that the USA dollar had in the USA at a given point in time) (WHO, 2019).
A study that examined the causes of under-five mortality showed that the mortality burden was highest in Africa in 2010 (3.6 million deaths) (Liu et al., 2012). The authors found that neonatal deaths account for 30% of total mortality and birth complications and intrapartum-related complications as the main causes. Recent studies continue to conclude that neonatal deaths account for a significant proportion of total deaths in Africa, particularly in sub-Saharan Africa (e.g. Ou et al., 2022; UN, 2022; Wang et al., 2014).
Considering these statistics, the international community recognized the need to develop and implement strategies to reduce the negative impact of limited NC. In this regard, NC research is crucial, although there is no study on the topic in Africa.
Bibliometrics allows for meaningful analysis of a particular topic, and this method can be used to identify strengths and weaknesses. The output from this analysis can assist: (1) scientists in ongoing or new NC research and (2) those responsible for policies to combat poor NC.
In this paper, I resorted to a bibliometric analysis to inform about the volume, impact, thematic spectrum, and collaboration patterns regarding NC research in Africa. Based on these results, I point out some implications for practice, policy and future research.
The paper is organized as follows: the next section provides a summary of the methodology (see Supporting Information (SI) for details), the Results and Discussion section presents the results of the bibliometric analysis and discusses its implications, and the Conclusions section presents the main findings.
Methods
Data Identification
I searched the keywords related to NC, validated by peers in Confraria & Wang, 2020, in titles, abstracts and keywords to find the relevant articles indexed in the Web of Science Core Collection (WoS) and published between 2000 and 2019 (see the search query in the Support Information (SI)). I extracted the metadata of 1784 articles published by at least one scientist (not all authors of a publication are scientists in the strict sense of the word, but for simplicity, I use this word to refer to the authors in the publications) whose affiliation is with an African institution (hereafter African scientists). The use of discipline–specific terms imposes limitations that affect the accuracy of the methodology due to the multiple meanings and variety of terms that can be used to represent a topic. I then analyzed each article and retrieved those referring to NC in Africa. The final set comprises 1250 articles. The limitations of the methodology are described in the SI.
Bibliometric Analysis
Volume
I used the number of articles to quantify the scientific knowledge on NC in Africa. Where possible, I resorted to longitudinal analyses to identify trends. I also identified the African countries researching NC.
Impact
I looked at the visibility of NC research by using, as a proxy, the number of citations. The number of citations depends on the citation culture of each field, type of document, and year of publication (Clarivate, 2021; Waltman, 2016). Then, I resorted to a normalized indicator: the Category Normalized Citation Impact (CNCI), available in InCites (Clarivate, 2021).
The CNCI of a document is the ratio between the number of citations received and that expected for documents of the same type, published in the same year and belonging to the same scientific field. If the CNCI for a particular document is above 1, the visibility of a document is above the world average, otherwise, it is below.
For document sets, I discussed their visibility using the median value. The CNCI is only addressed for sets with 20 or more articles (see the Methods in the SI for these decisions).
Thematic Spectrum
As for the thematic spectrum, I adopted the citation topics schema. This is a document-level classification available through the WoS (for more information on this schema, see the Methods in the SI). I used the micro-level to identify the topics covered in NC research. At this level, each paper is categorized into only one topic.
For each topic with 20 or more articles, I used the CNCI to determine its visibility.
Collaboration Activities
As for collaboration activities, I analyzed the patterns at the country and university level, domestic research collaboration (DRC) and IRC. The heuristics I followed can be found in the Methods in the SI.
After the identification of the countries, universities, and types of collaboration, I identified the:
- number of collaborative articles, type of collaborations and partners. I supplemented the information with a longitudinal analysis where possible,
- DRC by African country,
- visibility by type of collaboration,
- areas with more collaboration, and
- collaboration networks and analyzed them using social network analysis.
In the networks, the nodes represent countries/universities and the links are the number of publications in which the scientists from the two countries/universities have participated. I used statistics as the density, degree, and eigencentrality (Cherven, 2015) to discuss the potential of these networks as enablers of knowledge flow.
Results and Discussion
Volume
The knowledge on NC has increased over time. In 2000, there are 15 articles indexed in WoS and in 2019, 196 (Figure 1). The growth can be described as exponential, with an annual growth rate of around 19%.
The production is concentrated in the period between 2010 and 2019, mainly in 2015–2019 when about 61% of the 1250 articles were published (Figure 1).
A large proportion of the scientific knowledge produced is the responsibility of a few African countries: Egypt, South Africa, Nigeria, Tanzania and Kenya were involved in 787 articles, representing about 63% of all articles (SI, Table 1). This suggests that knowledge may be concentrated in a few places, which is undesirable as the burden greatly affects the whole continent.
These countries are also consistently among the African leaders in the production of knowledge in general (e.g., Cerdeira, Mesquita, & Vieira, 2023; Mouton & Blanckenberg, 2018; Sooryamoorthy, 2021). Therefore, their national scientific systems are expected to have characteristics that put them in a satisfactory position regarding knowledge transfer to other African countries.
Over time, there have been no significant changes in the African countries with the highest contribution (SI, Table 1). Egypt has significantly increased its production; two papers were published in 2000–2004 and 150 in 2015–2019, the country with the highest number. The changes in 2015–2019 indicate that other countries might play a crucial role in NC research in the future. While Egypt, South Africa and Nigeria remain in the top 5, Tanzania and Kenya have been overtaken by Ethiopia. Uganda and Ghana have a similar number of articles to Tanzania.
Impact
The distribution of articles according to their impact is skewed (SI, Figure 1). There are a few articles with a high impact (60 articles have a CNCI of 5 or more) and many articles with a value below the world average (749 articles with a CNCI of less than one and 455 with 0.500 or less).
The impact of the articles is, generally, below the world average according to the median value (Figure 2, left plot). It is 0.754 the world average (SI, Table 2) considering all documents. It increased from 2000–2004 (articles published in this period) to 2010–214 and then declined (Figure 2, right plot), without reaching the world average. In 2015–2019, the median value is 0.85 of the world average. However, as mentioned before and shown in SI, Table 2, some articles have an outstanding impact (interquartile range (IQR) and P75).
Thematic Spectrum
The distribution by topic is skewed (SI, Table 3); 159 topics and those in the top 5 account for 45% of the 1250 articles. For 83 topics, the number of articles is one.
Maternal Mortality, Group B Streptococcus, Bilirubin, Preterm Labor, and Gestational Diabetes Mellitus dominate the top 5 across the period (Figure 3). This is partly a consequence of the unbalanced distribution of documents by period (these topics dominate the top 5 in 2015–2019, when the number of articles is highest). Over time, we see changes; Gastroschisis, Patent Ductus Arteriosus, Fetal Heart Rate, Malaria and Preeclampsia were in the top 5 in the first two periods.
For topics with 20 or more articles in 2000–2019, visibility is below the world average, except for Bilirubin, HIV Prevalence & Prophylaxis, Malaria, and Antibiotic Resistance, which are slightly above the world average (SI, Table 3 and Table 4). Articles on HIV Prevalence & Prophylaxis have the highest impact, median value of 1.105. The articles on Patent Ductus Arteriosus have the lowest visibility; 0.586 the world average.
Collaboration Activities
Overview of Research Collaboration
Collaborative activities are common in NC research (Figure 4) and have increased. In 2000–2019, there are 555 articles with DRC and 669 with IRC (SI, Table 5). The growth can be characterized as exponential, with an annual growth rate of about 23% for IRC and 17% for DRC. In 2000, collaborative activities are present in all articles and in 2019, in 98%. Considering 5-year periods, we see that DRC is more frequent than IRC in 2000–2004; it is about two times the frequency of IRC (Figure 4), although the number of articles is small. Over time, IRC has become more frequent and accounts for 54% of all articles in 2015–2019, while DRC accounts for 45% (SI, Table 5).
Among the types of IRC, collaboration between African scientists without the participation of non-African scientists (IRCintra) was rare. We find 19 articles in 2000–2019, and 16 in 2015–2019 (SI, Table 5).
Articles in which African scientists from various countries and non-African scientists (IRCinter_intra) contributed were practically non-existent until 2009. After that, the number of these articles began to increase; in 2015–2019 they represent 18.5 % of all articles (SI, Table 5).
This rare pattern of collaboration (IRCintra and IRCinter_intra) may not allow the development and establishment of networks among African scientists that permit them to address their local challenges. These collaborations provide insights to answer current research questions and offer African scientists the opportunity to share their previous experiences, acquired knowledge and the challenges in their countries through informal communication. As they interact and realize each other’s capabilities and interests, trusting relationships are formed. These relationships and previous collaborations can lead to new joint projects that address local issues (Cerdeira, Mesquita, & Vieira, 2023; Owusu-Nimo & Boshoff, 2017). In addition, trusting relationships may spread among the collaborators of African scientists involved in IRCintra and IRCintra_inter, increasing opportunities for collaboration with these scientists’ partners (Newman, 2001). In short, it is expected that all mechanisms involved in collaborative activities will contribute to building a stronger research network between African scientists from different countries with or without the presence of non-African scientists.
Collaboration between African scientists, all from the same country, and non-African scientists (IRCinter) is the most common, in 88.2% of all articles in 2000–2004 and 77.6% in 2015–2019 (SI, Table 5). The benefits of these joint activities can be maximized if the African scientists involved have well-established national and intra/interregional African networks. In this scenario, they can serve as a bridge between other African scientists representing their professional connections in Africa and the non-African scientists involved in IRCinter.
Collaboration Networks
If we look at the network behind NC research, we can speculate on the potential benefits of IRC from this perspective.
NC research is characterized by high geographical dispersion as the network consists of 129 countries (89 non-African and 40 African countries, SI, Figure 5). There are 5059 links, which account for 61% of all possible interactions given the number of countries involved. The interactions between non-African countries (the links connecting two non-African countries) dominate the network as they account for 57.4% of all links (SI, Figure 5), followed by the interactions between African and non-African countries, which account for 36.3% of all links. Finally, interactions between African countries account for 6.3% of all links. In the network, 2192 links (43.3% of all links) represent a single publication in 20 years.
Collaborations between African countries appear to be fragile, as the subnetwork related to these interactions has 60% of its links representing only one article in 20 years (Figure 5). When these links are removed, the number of African countries with links to another African country drops from 40 to 25.
The subnetwork of the collaborations between African and non-African countries (SI, Figure 6) also shows weaknesses, as the links representing one publication in 20 years account for 49% of all its links. The Republic of Congo, Liberia, South Sudan, and Togo, which also have a fragile position in Figure 5, albeit Togo to a lesser extent, lost all their connections to non-African countries when the links representing one publication are deleted (SI, Figure 7). In addition, African countries lost connections with 15 non-African countries (Albania, Armenia, Bhutan, Bosnia and Herzegovina, Haiti, Hungary, Jamaica, Kazakhstan, Latvia, Malta, Montenegro, Myanmar, North Macedonia, Syria and Yemen).
The subnetworks indicate that Ghana, Nigeria, Tanzania and Kenya can play an important role in the flow of knowledge, in the continent, and in establishing professional links between African countries. They are quite well connected with other African countries within and outside their region (28 countries in the case of Kenya and 29 for the others). South Africa can also be crucial but is not well connected within Southern Africa. In 20 years, it co-authored a single publication with Botswana. If we ignore the links representing one article, the top 5 consist of the same countries and Uganda also appears at the top.
These countries, in addition to Egypt and Zambia, have the highest number of connections to non-African countries. They are influential in the network, as they are connected to countries with many connections also as supported by the high values of eigencentrality (SI, Table 8).
Figure 5.
Collaboration subnetwork between African countries in 2000–2019 (the subnetwork derived from Figure 5, SI).
Figure 5.
Collaboration subnetwork between African countries in 2000–2019 (the subnetwork derived from Figure 5, SI).

As for non-African countries, the USA and the UK are key players in the flow and access to knowledge as shown by the high number of connections and centrality (they have the highest values for degree and eigencentrality, SI, Table 8).
The role of these countries becomes even clearer when analyzing the number of jointly authored articles by African countries (SI, Table 7). They are among the 5 countries that collaborated the most with African countries in 2000–2019 and in each 5 years. In 2000–2019, about 57% and 28% of the articles with IRC have the collaboration of scientists from the USA and the UK, respectively.
Sweden, the Philippines, and Switzerland lost their positions in this top. Their contribution is limited to two and three articles respectively in 2000–2004 (SI, Table 7), while others such as India, Canada, Pakistan and France emerged, although Pakistan and France are no longer at the top in 2015–2019. The research with multinational clinical trials conducted in India, Pakistan, African countries and other regions could justify the high presence of India and Pakistan at the top.
627 universities participated in IRC (SI, Table 9), and they are present in 96% of all articles with IRC. The distribution of universities by region is asymmetrical, as non-African universities predominate, although those from Africa increased over time (SI, Table 10). In 2015–2019, there are 126 African universities, accounting for 22% of all universities. The distribution of universities by country is also skewed, as those from the USA represent 18.5% of all universities in 2000–2019, followed by the UK with 4.8%.
The University of London (UoL-GBR) is the leader given the number of articles in which it was involved in the entire period, followed by the University of California (UC-System-USA) (Table 1). Other well-known universities are present in the top 10, such as Harvard University (HU-USA), Johns Hopkins University (JHU-USA), the University of North Carolina (UNC-System-USA) and the University of Oxford (OX-GBR). As for African universities, the University of Malawi (UNIMA-MWI), the University of Makerere (Mak-UGA) and the University of Witwatersrand (Wits Univ-ZAF) published more articles with IRC in 2000–2019. Over time, the changes in the top 10 are not significant. We see changes from the first to the second 5-year period, but the number of articles we are dealing with is so small that an in-depth discussion is impossible.
Table 1.
Universities in the top 10 (highlighted in blue) according to the number of publications with IRC in each period.
Table 1.
Universities in the top 10 (highlighted in blue) according to the number of publications with IRC in each period.
| Country | Institution | Pub (nº) | ||||
|---|---|---|---|---|---|---|
| 2000–2019 | 2000–2004 | 2005–2009 | 2010–2014 | 2015–2019 | ||
| Egypt | MA-EGY | 10 | 0 | 4 | 1 | 5 |
| Ethiopia | AAU-ETH | 15 | 1 | 0 | 2 | 12 |
| Malawi | UNIMA-MWI | 42 | 1 | 4 | 9 | 28 |
| Mozambique | UEM-MOZ | 6 | 1 | 0 | 2 | 3 |
| Pakistan | AKU-PAK | 46 | 0 | 2 | 17 | 27 |
| Tanzania | MUHAS-TZA | 31 | 2 | 6 | 11 | 12 |
| South Africa | Wits Univ-ZAF | 39 | 0 | 4 | 11 | 24 |
| Uganda | Mak-UGA | 44 | 1 | 3 | 10 | 30 |
| Zimbabwe | UZ-ZWE | 10 | 2 | 0 | 2 | 6 |
| Australia | UNIMELB-AUS | 17 | 2 | 3 | 4 | 8 |
| Norway | UiB-NOR | 20 | 1 | 1 | 9 | 9 |
| Sweden | KI-SWE | 17 | 2 | 2 | 6 | 7 |
| UK | OX-GBR | 41 | 1 | 5 | 10 | 25 |
| UK | UoL-GBR | 106 | 0 | 14 | 26 | 66 |
| USA | JHU-USA | 53 | 4 | 9 | 17 | 23 |
| USA | CU-USA | 33 | 2 | 2 | 3 | 26 |
| USA | HU-USA | 57 | 2 | 6 | 15 | 34 |
| USA | UNC-System-USA | 49 | 0 | 7 | 10 | 32 |
| USA | GWU-USA | 17 | 0 | 4 | 6 | 7 |
| USA | UA-System-USA | 35 | 0 | 2 | 17 | 16 |
| USA | UC-System-USA | 65 | 0 | 3 | 16 | 46 |
| USA | UW-USA | 35 | 0 | 3 | 11 | 21 |
The collaboration network has 627 universities and 48468 links (SI, Figure 8). The visible links represent 25% of the possible interactions between the participating universities. The interactions between non-African universities dominate the network as they account for 77% of all links (SI, Figure 8), followed by the interactions between African and non-African universities, which are 21% of all links. Finally, interactions between African universities account for 2% of the observed links.
The network is characterized by a dense core dominated by non-African universities. There are clusters of universities that are closely connected to this core. If we move from the core to the periphery, the network consists of small groups of universities with weak connections to each other and fragile connections to the core.
This network can be considered too fragile as 67% of the links represent a publication in 20 years. If these links are deleted, the network consists of 477 universities (397 and 80 African and non-African universities, respectively).
Regarding the subnetwork among African universities, it cannot be said that it is a mature and well-established network, as several universities have a very fragile position (SI, Figure 9). 17 out of 138 universities have no connections to other African universities; they are part of the network because they are only linked to non-African universities. 557 out of 804 links represent one publication in 20 years. If we delete these links, only 48 African universities will still be connected and most of the small groups of African universities, which are at the network periphery, disappear.
The University of Cairo in Egypt (CU-EGY), MUHAS-TZA in Tanzania, Wits Univ-ZAF in South Africa, University of Kinshasa in the Democratic Republic of Congo (UNIKIN-ZAR) and University of Cape Coast in Ghana (UCC-GHA), from different African regions, can play an important role in the flow of knowledge between African universities as they are linked to several universities in other countries from their region and also from other African regions, except Wits Univ-ZAF and UNIKIN-ZAR. Although they are linked to universities in other African regions, they have no joint publications with countries within their region.
It is important to know which African universities can play a crucial role in the flow of knowledge and the expansion of professional relationships within the continent and to identify those that stand out for their links with non-African universities. The role of the above universities is diminished by the absence or presence of a small number of links with non-African universities.
The subnetwork between African and non-African universities, which includes 600 universities (SI, Figure 10), is also fragile, as the number of links representing one publication is 6896 out of its 10409 links. Most African universities have at least one publication with non-African universities, as 127 out of 138 are in the subnetwork. However, the presence of African universities seems delicate as only 74 remain in the subnetwork if the links representing one publication are deleted. In addition, many connections with non-African universities are lost as the number of these universities drops to 239.
Despite these weaknesses, we find African universities that occupy an outstanding position. The universities highlighted above (SI, Figure 9), as well as the University of Ahmadu Bello (ABU-NGA), the University of Stellenbosch (SU-ZAF) and the University of Cape Town (UCT-ZAF) (from Nigeria and South Africa) have the most connections with non-African universities. They are also among the universities with the highest centrality in the network (except for UNIKIN-ZAR), as shown by the eigencentrality values (SI, Table 11).
Finally, as far as non-African universities is concerned, outstanding universities such as UoL-GBR, OX-GBR and UW-USA are important in NC research, as shown by their high number of connections and their centrality in the network (SI, Table 11). These institutions have the most connections to African universities (about 14% of their total connections).
DRC Activities
As for DRC, Egypt, Nigeria, South Africa and Tunisia are among the top 3 countries with the highest number of documents in each period, although, Tunisia’s presence is marginal as only two articles were identified in 2000–2004 (SI, Table 6). These countries account for 74% of all articles with DRC. Although the changes concerning DRC are positive for these countries, this concentration indicates a low level of interaction between African scientists within the boundaries of the remaining countries.
As for Egypt, Nigeria and South Africa, it seems that each country is trying to solve its local problems by drawing on local knowledge, as the number of articles with DRC increased, albeit at different rates.
South Africa, which had the highest number of articles with DRC in 2000–2004, about 47% of all articles in that period, was displaced in the following period by Nigeria, which has about 39% of all articles in 2005–2009. In 2010–2014, Nigeria lost its first place to Egypt, which retained the lead in 2015–2019. The relative weight of articles with DRC from South Africa decreased over time, while articles from Egypt increased, accounting for about 34% of all articles with DRC in 2015–2019.
The data indicates that Ethiopia has made a significant commitment to DRC over the last five years. While there were no interactions within the borders in the previous periods (SI, Table 6), articles with DRC in 2015–2019 account for 14% of all articles with DRC in that period.
Visibility and Thematic Spectrum of Collaborative Activities
Research involving scientists from several countries leads to results with greater visibility than research conducted only within borders, as the CNCI values show (SI, Table 12). The median value is 0.5 of the world average for articles with DRC, and the value has not changed much over time. As for the articles with IRC, the median values are very close to the world average, and the highest value is recorded for articles published in 2010–2014; 1.272 the world average (SI, Table 12). The highest visibility of articles with IRC was also highlighted in previous studies Vieira, 2023.
Although the articles with IRCinter are prevalent in NC research, articles with IRCinter_intra have a higher visibility (articles published in 2010–2014 and 2015–2019, SI, Table 13). Articles with IRCinter_intra and published in 2010–2014 have a median value that is twice as high as the world average and 1.5 times as high as for articles with IRCinter in the same period. For the most recent articles (2015–2019), visibility decreased for both types of IRC. -
Maternal Mortality, Group B Streptococcus, Bilirubin, Gestational Diabetes Mellitus and Preterm Labor collaborated the most in the entire period (SI, Table 14). Therefore, the distribution is very similar to Figure 3.
Maternal Mortality and Group B Streptococcus have the largest number of collaborative articles in each 5 years. However, the thematic spectrum is dynamic, with Bilirubin and Fetal Heart Rate emerging at the top in 2005–2009, Bilirubin maintaining its position and Preterm Labor appearing in the last period (SI, Table 14).
It has been argued that the scientific production of African countries is dependent on the contribution of foreign scientists Vieira & Cerdeira, 2022. However, the data show that different patterns can be found depending on the level of analysis.
Among the topics for which there are documents with IRC or DRC, IRC is the most common in 25 topics, and in the top 5, we have Maternal Mortality, Gestational Diabetes Mellitus, HIV Prevalence & Prophylaxis, and Malaria. The number of articles with IRC is about three times as high as those with DRC (SI, Table 15). As for Fetal Heart Rate, the distribution is more balanced, and the difference is one document.
DRC is the most frequent in 24 topics, and in the top 5 we find Group B Streptococcus, Bilirubin, Preeclampsia, Preterm Labor and Patent Ductus Arteriosus (SI, Table 15). Still, the differences between DRC and IRC are not as pronounced as in the previous case, except for Patent Ductus Arteriosus.
The IRC articles’ visibility is above that of articles with DRC for the topics with 20 or more articles (SI, Table 16). Except for Group B Streptococcus and Gestational Diabetes Mellitus, the visibility of articles with IRC is twice as high as that of articles with DRC. For these topics, the visibility regarding the presence of IRC is also close to or slightly above the world average, except for Bilirubin with a median value of 1.5 times the world average.
Conclusions
The literature shows that neonatal deaths account for a significant proportion of all deaths in children under 5 years of age in Africa. Poor NC is often cited as the main cause of neonatal deaths (Nieuwoudt, Mackay, & Mda, 2022; UN, 2024). Although there have been several efforts to improve NC in this region, no study addresses the scientific knowledge of NC. The quantity, impact, scientific spectrum and collaborations patterns behind this knowledge can be used by scientists in ongoing and new NC research and stakeholders developing and implementing strategies to combat poor NC.
I looked at the literature on NC in Africa and used a bibliometric analysis to describe NC research. The results are important for practice, policy, and future research.
NC research attracted the interest of the scientific community as the number of articles increased from 15 in 2000 to 196 in 2019. However, it is not examined if this research addresses local needs. Future research should focus on this.
NC research is concentrated in a few African countries: Egypt, South Africa, Nigeria, Tanzania and Kenya. Strategies are needed to increase research in other African countries, and they could consider involving these countries as partners.
NC research has low visibility, in general. However, some articles have aroused great interest. This is the case of Bilirubin research involving scientists from several countries. Future research should shed more light on this point. The low visibility could be because the results are not relevant in the context of high-income countries, as their scientific problems are different (Atal et al., 2018; Evans, Shim, & Ioannidis, 2014). In this situation, the main interested in the research’s findings are in Africa.
Maternal Mortality, Group B Streptococcus, Bilirubin, Preterm Labor, and Gestational Diabetes Mellitus are the most studied topics. Future research should investigate whether these topics represent the main challenges regarding NC. If this is not the case, the issues that need more attention should be prioritized.
NC research is highly collaborative, with IRC occurring most frequently, namely between African scientists from the same country and non-African scientists. Future research may look at the positive and negative consequences of this mainly from the perspective of the interactions between the academic, government and industrial sectors.
Research only between African scientists from different countries is rare. Strategies to expand and strengthen research collaboration should focus on these collaborations.
The networks behind NC research are fragile, as most links (43%-67%) between countries/universities represent one publication in 20 years. Ghana, Nigeria, South Africa, Tanzania, Kenya, Egypt and Zambia have high centrality in the network. CU-EGY, MUHAS-TZA, Wits Univ-ZAF, SU-ZAF, UCT-ZAF, UNIKIN-ZAR, UCC-GHA and ABU-NGA have the most linkages with African and non-African universities, except UNIKIN-ZAR, which has no linkages with African universities from other countries. Strategies addressing the flow of knowledge and expansion of networks within the continent should consider these countries/universities as possible bridges. Ongoing or new NC research should consider these countries/universities as possible partners.
The USA and the UK are the main partners, as are the universities of these countries, especially those known for their excellence (e.g. HU-USA, JHU-USA, UoL-GBR, OX-GBR). Strategies that address knowledge sources should emphasize geographical diversification, while maintaining links with the US and UK, to reduce dependence on knowledge from these countries.
Research with IRC has the highest visibility. Strategies aimed at attracting the scientific community should emphasize IRC but always ensure that research meets local needs.
Disclosure Statement: The authors report there are no competing interests to declare.
Support Information: The following supporting information can be downloaded at the website of this paper posted on Preprints.org. The support information includes additional information about the methods used and their main limitations. It also presents several tables, figures and networks that supplement the Results and Discussion section in the main text.
Methods
Data Identification
The search query used to get the publications from the WoS Core Collection is as follows:
((ts="Preterm birth" OR ts="Birth asphyxia" OR ts="birth trauma" OR ts="Neonatal sepsis" OR tss="neonatal infection*" OR ts="Gastroschisis" OR ts="Jaundice" OR ts="Necrotizing enterocolitis" OR ts="Persistent pulmonary hypertension of the newborn" OR ts="Intrauterine growth restriction" OR ts="Bronchopulmonary dysplasia" OR ts="infant apnoea" OR ts="infant respiratory distress syndrome" OR ts="asphyxia at birth" OR ts="anaemia in neonates" OR ts="neonatal alloimmune thrombocytopenia" OR ts="bronchopulmonary dysplasia" OR ts="cardiac failure in neonates" OR ts="hyaline membrane disease" OR ts="hypocalcaemia in neonates" OR ts="hypoglycaemia of the newborn" OR ts="hyponatraemia in neonates" OR ts="hypothermia in neonates" OR ts="intestinal obstruction in neonates" OR ts="pulmonar interstitial emphysema”) and (cu="South Africa" OR cu="Egypt" OR cu="Nigeria" OR cu="Ethiopia" OR cu=” Rep Congo” OR cu=”DEM Rep Congo” OR cu="Tanzania" OR cu="Kenya" OR cu="Algeria" OR cu="Sudan" OR cu=”south sudan” OR cu="MORocco" OR cu="Uganda" OR cu="Mozambique" OR cu="Ghana" OR cu="angola" OR cu="somalia" OR cu="Ivory Coast" OR cu=”cote ivoire” OR cu="Madagascar" OR cu="Cameroon" OR cu="Burkina Faso" OR cu="Niger" OR cu="Malawi" OR cu="zambia" OR cu="mali" OR cu="Senegal" OR cu="Zimbabwe" OR cu="Chad" OR cu="Tunisia" OR cu="Guinea" OR cu="Guinea bissau" OR cu=”Equat Guinea” OR cu="Rwanda" OR cu=" Benin" OR cu="Burundi" OR cu="Eritrea" OR cu="Sierra Leone" OR cu="Togo" OR cu="Libya" OR cu="CENT AFR REPUBL" OR cu="Mauritania" OR cu="Liberia" OR cu="Namibia" OR cu="Botswana" OR cu="Lesotho" OR cu="Gambia" OR cu="Gabon" OR cu="Mauritius" OR cu="Eswatini" OR cu=”swaziland” OR cu="Djibouti" OR cu="Comoros" OR cu="Cape Verde" OR cu=" SAO TOME & PRIN " OR cu="Seychelles") and py=2000–2019)
Limitations
As for the method used to extract the articles on NC, the less positive points must be emphasized.
Non-African scientists, mainly those from high-income countries (HICs) might conduct research on NC in Africa without the participation of African scientists, a phenomenon known in the literature as parachute science (e.g., Stefanoudis et al., 2021). However, we should emphasize the results from the literature of the research done by scientists from HICs on the greatest burden of disease. Most of the research on Medical and Health Sciences (M&HS), which includes NC, has been done by HICs and they have addressed their local scientific problems, which are very different from those of Africa (Atal et al., 2018; Evans, Shim, & Ioannidis, 2014). As for neonatal disorders, results have shown that disease-specific gaps exist in Sub-Saharan Africa (Atal et al., 2018) and that the burden is very prevalent in Africa in general (Ou et al., 2022).
In M&HS, in specific, research involving African and non-African scientists unveiled that while 67% of the total 520 clinical trials conducted in Africa addressed local scientific problems, in 14% of cases the research addressed the needs of developed countries. Therefore, I can not guarantee that all the NC research identified is related to the local needs in Africa.
Impact
Normally, when determined for a set of documents, the CNCI is the average value of the CNCI of all documents. However, when using this indicator, we must consider that the citation distribution of documents is typically skewed (Vieira & Gomes, 2010). We normally find a small number of documents highly cited and many documents with relatively few citations (Figure 1 in this document). The mean value is affected by highly cited documents therefore the average values might not represent well the impact/visibility. Thus, I decided to present the median, which is not affected by the presence of highly cited documents. The distribution of the values of CNCI (Figure 1, Figure 3, Figure 4 in this document) shows that indeed the average value is not a good choice.
When dealing with small sets of documents, the probability of finding a median value of zero is high given that many documents are never cited, and others given their recent publication did not have the time to be acknowledged by the scientific community. Therefore, I only discuss these indicators for sets with 20 or more articles. However, I present the values for sets with less than 20 documents only for information purposes.
Lastly, in calculating the CNCI, I used an open window, i.e. the count of citations represents the cumulative citations between the publication year and September 2023 (the moment when I collected the data from the WoS).
Thematic Spectrum
The citation topics schema names clusters of documents based on cited and citing relationships between documents (Potter, 2020). This is a three-level hierarchical document classification system. The macro, meso and micro level include 10, 326, and 2449 scientific fields, respectively. At the micro-level, each paper is categorized into only one topic. The schema is a dynamic one, meaning that every year the number of scientific fields can change. Some topics might require a change in the name, and others might be added. Therefore, every year, we have an update of the schema. The data presented here is based on the schema available for 2023.
Collaboration
As for collaboration, I followed the following heuristics:
- Using the author’s affiliation(s) in the articles, I extracted information concerning the country and universities.
- I only considered universities given that they are the main players in the discovery and creation of knowledge.
- As for universities. I aggregated the information at the higher level of the organization (e.g., information is not available for departments or individual faculties belonging to a given university). In the case of the USA, the results are presented for the university system and not for the individual campuses. For example, the University of California is a university system composed of ten campuses. All the articles mentioning the different campuses of the university were considered as University of California.
- As for IRC, I identified the articles that have at least two authors whose affiliations mention institutions located in two countries. Once the articles with IRC have been identified, I analyzed them with more detail and identified occurrences between: (1) African scientists all from the same country and non-African scientists (IRCinter); (2) only African scientists from different countries (IRCintra); (3) African scientists from different countries and non-African scientists (IRCinter-intra).
- Concerning DRC, I considered articles that only represent collaborations between scientists working in the same or different institutions in each African country.
Results
Volume
Table 1.
Number of articles on NC by African country, for the whole period and by 5-year periods.
| Country | Pub (nº) | ||||
|---|---|---|---|---|---|
| 2000–2019 | 2000–2004 | 2005–2009 | 2010–2014 | 2015–2019 | |
| EGYPT | 232 | 2 | 21 | 59 | 150 |
| SOUTH AFRICA | 212 | 21 | 27 | 51 | 113 |
| NIGERIA | 186 | 9 | 27 | 52 | 98 |
| TANZANIA | 101 | 4 | 13 | 29 | 55 |
| KENYA | 92 | 4 | 4 | 24 | 60 |
| ETHIOPIA | 81 | 2 | 0 | 5 | 74 |
| UGANDA | 77 | 1 | 4 | 18 | 54 |
| GHANA | 75 | 1 | 6 | 15 | 53 |
| MALAWI | 64 | 2 | 6 | 10 | 46 |
| ZAMBIA | 52 | 0 | 3 | 18 | 31 |
| GAMBIA | 31 | 2 | 3 | 4 | 22 |
| TUNISIA | 24 | 2 | 5 | 6 | 11 |
| CONGO DEMOCRATIC REPUBLIC | 21 | 0 | 2 | 5 | 14 |
| MOROCCO | 20 | 0 | 1 | 8 | 11 |
| CAMEROON | 20 | 0 | 0 | 7 | 13 |
| ZIMBABWE | 20 | 2 | 1 | 4 | 13 |
| SUDAN | 19 | 1 | 4 | 3 | 11 |
| SENEGAL | 19 | 1 | 3 | 6 | 9 |
| BENIN | 14 | 0 | 1 | 4 | 9 |
| BURKINA FASO | 13 | 0 | 0 | 1 | 12 |
| MOZAMBIQUE | 13 | 1 | 0 | 3 | 9 |
| RWANDA | 13 | 0 | 0 | 1 | 12 |
| COTE IVOIRE | 10 | 0 | 0 | 3 | 7 |
| MADAGASCAR | 10 | 0 | 0 | 2 | 8 |
| BOTSWANA | 10 | 0 | 0 | 0 | 10 |
| GABON | 8 | 0 | 0 | 2 | 6 |
| MALI | 6 | 0 | 0 | 5 | 1 |
| NIGER | 5 | 0 | 0 | 0 | 5 |
| ALGERIA | 4 | 1 | 0 | 1 | 2 |
| TOGO | 3 | 0 | 1 | 0 | 2 |
| SIERRA LEONE | 3 | 0 | 0 | 0 | 3 |
| BURUNDI | 3 | 0 | 0 | 0 | 3 |
| CONGO PEOPLES REP | 3 | 0 | 0 | 1 | 1 |
| CENT AFR REPUBL | 2 | 0 | 0 | 0 | 2 |
| GUINEA BISSAU | 2 | 0 | 0 | 1 | 1 |
| SOUTH SUDAN | 2 | 0 | 0 | 0 | 2 |
| LIBYA | 2 | 0 | 0 | 1 | 1 |
| ANGOLA | 2 | 1 | 0 | 0 | 1 |
| CHAD | 2 | 0 | 0 | 0 | 2 |
| LIBERIA | 1 | 0 | 0 | 0 | 1 |
| ERITREA | 1 | 0 | 1 | 0 | 0 |
Impact
Figure 1.
Distribution of the CNCI of the articles on NC published between 2000 and 2019. Due to visualization purposes, only articles with a CNCI equal to or below 20 were considered (they represent 99.2% of the total articles).
Figure 1.
Distribution of the CNCI of the articles on NC published between 2000 and 2019. Due to visualization purposes, only articles with a CNCI equal to or below 20 were considered (they represent 99.2% of the total articles).

Figure 2.
Evolution of the average CNCI for the articles on NC.

Figure 3.
Boxplot for the values of CNCI of the articles published between 2000 and 2019.

Figure 4.
Boxplot for the values of CNCI of the articles by period.

Table 2.
Descriptive statistics for the CNCI.
| Statistics | CNCI | ||||
|---|---|---|---|---|---|
| 2000–2019 | 2000–2004 | 2005–2009 | 2010–2014 | 2015–2019 | |
| Median | 0.754 | 0.430 | 0.721 | 0.850 | 0.744 |
| Stand. Dev. | 9.136 | 0.576 | 1.221 | 13.877 | 7.562 |
| P25 | 0.308 | 0.236 | 0.328 | 0.409 | 0.294 |
| P75 | 1.535 | 0.857 | 1.361 | 1.748 | 1.536 |
| IQR | 1.227 | 0.622 | 1.033 | 1.339 | 1.242 |
| Observations | 1250 | ||||
Thematic Spectrum
Table 3.
Number of articles on NC by topic.
| Micro-topic | Pub(nº) | ||||
|---|---|---|---|---|---|
| 2000–2004 | 2005–2009 | 2010–2014 | 2015–2019 | 2000–2019 | |
| 1.156.381 Maternal Mortality | 8 | 21 | 57 | 108 | 194 |
| 1.23.1757 Group B Streptococcus | 8 | 9 | 28 | 83 | 128 |
| 1.117.1389 Bilirubin | 1 | 8 | 24 | 58 | 91 |
| 1.72.182 Gestational Diabetes Mellitus | 3 | 7 | 26 | 54 | 90 |
| 1.72.924 Preterm Labor | 2 | 6 | 11 | 45 | 64 |
| 1.72.531 Preeclampsia | 3 | 9 | 11 | 37 | 60 |
| 1.66.11 HIV Prevalence & Prophylaxis | 1 | 5 | 12 | 31 | 49 |
| 1.217.59 Malaria | 1 | 6 | 15 | 18 | 40 |
| 1.72.922 Fetal Heart Rate | 0 | 9 | 6 | 23 | 38 |
| 1.72.1732 Patent Ductus Arteriosus | 3 | 1 | 9 | 12 | 25 |
| 1.72.748 Preterm Infants | 0 | 1 | 9 | 13 | 23 |
| 1.23.146 Antibiotic Resistance | 0 | 1 | 3 | 17 | 21 |
| 1.216.2287 Gastroschisis | 3 | 2 | 1 | 14 | 20 |
| 1.44.1198 Food Insecurity | 0 | 0 | 9 | 10 | 19 |
| 1.72.808 Breech Presentation | 1 | 1 | 1 | 14 | 17 |
| 1.184.573 Iron Overload | 1 | 1 | 4 | 7 | 13 |
| 1.248.655 Chlamydia Trachomatis | 0 | 2 | 1 | 10 | 13 |
| 1.72.891 Breastfeeding | 1 | 2 | 2 | 7 | 12 |
| 1.125.1718 Hepatitis E Virus | 2 | 3 | 1 | 5 | 11 |
| 1.72.1072 Postpartum Depression | 0 | 1 | 1 | 9 | 11 |
| 1.80.279 Vitamin D | 0 | 1 | 0 | 10 | 11 |
| 1.225.2074 Methemoglobinemia | 0 | 0 | 6 | 4 | 10 |
| 1.49.468 Oral Health | 0 | 0 | 2 | 8 | 10 |
| 1.154.1057 Pulmonary Surfactant | 1 | 2 | 2 | 4 | 9 |
| 1.150.1148 Deaf | 0 | 3 | 2 | 3 | 8 |
| 1.156.2047 Global Surgery | 0 | 1 | 2 | 5 | 8 |
| 1.157.728 Biliary Atresia | 1 | 1 | 1 | 5 | 8 |
| 1.75.326 Antiphospholipid Syndrome | 0 | 1 | 4 | 3 | 8 |
| 1.81.979 Twin-Twin Transfusion Syndrome | 0 | 1 | 4 | 3 | 8 |
| 8.124.552 Air Pollution | 0 | 0 | 1 | 6 | 7 |
| 1.120.384 Gut Microbiota | 0 | 0 | 2 | 4 | 6 |
| 1.55.830 Acute Kidney Injury | 0 | 2 | 0 | 4 | 6 |
| 1.148.94 Candida Albicans | 0 | 0 | 2 | 3 | 5 |
| 1.151.222 Laparoscopic Cholecystectomy | 0 | 0 | 0 | 5 | 5 |
| 1.225.626 Sickle Cell Disease | 0 | 0 | 1 | 4 | 5 |
| 1.103.1225 ITP | 0 | 1 | 3 | 0 | 4 |
| 1.104.975 Respiratory Syncytial Virus | 1 | 0 | 1 | 2 | 4 |
| 1.137.217 Melatonin | 0 | 0 | 0 | 4 | 4 |
| 1.154.360 Procalcitonin | 0 | 0 | 1 | 3 | 4 |
| 1.161.711 Cytomegalovirus | 0 | 2 | 1 | 1 | 4 |
| 1.23.173 Staphylococcus Aureus | 0 | 0 | 0 | 4 | 4 |
| 1.42.678 Listeria Monocytogenes | 1 | 1 | 0 | 2 | 4 |
| 1.82.1066 Cerebral Palsy | 0 | 0 | 3 | 1 | 4 |
| 1.104.126 Influenza | 0 | 0 | 1 | 2 | 3 |
| 1.125.275 HBV | 0 | 0 | 0 | 3 | 3 |
| 1.128.482 Contraception | 0 | 0 | 0 | 3 | 3 |
| 1.194.273 Mycobacterium Tuberculosis & Leprosy | 0 | 0 | 1 | 2 | 3 |
| 1.216.1563 Volvulus | 0 | 0 | 0 | 3 | 3 |
| 1.216.1996 Pneumomediastinum | 0 | 0 | 1 | 2 | 3 |
| 1.222.143 Epilepsy | 1 | 1 | 1 | 0 | 3 |
| 1.231.432 Homocysteine | 1 | 0 | 1 | 1 | 3 |
| 1.248.1317 Mycoplasma | 0 | 0 | 2 | 1 | 3 |
| 1.248.2104 Trichomonas Vaginalis | 1 | 0 | 1 | 1 | 3 |
| 1.257.983 Hydrocephalus | 0 | 0 | 2 | 1 | 3 |
| 1.37.309 Congenital Heart Disease | 0 | 0 | 1 | 2 | 3 |
| 1.72.1745 Hyperemesis Gravidarum | 0 | 0 | 2 | 1 | 3 |
| 1.95.723 Irritable Bowel Syndrome | 0 | 2 | 1 | 0 | 3 |
| 3.91.920 Selenium | 0 | 1 | 0 | 2 | 3 |
| 6.24.858 Intimate Partner Violence | 0 | 0 | 1 | 2 | 3 |
| 1.125.83 HCV | 1 | 1 | 0 | 0 | 2 |
| 1.141.407 Acute Promyelocytic Leukemia | 1 | 0 | 0 | 1 | 2 |
| 1.142.832 Fecal Incontinence | 0 | 0 | 1 | 1 | 2 |
| 1.161.315 HSV-1 | 0 | 0 | 2 | 0 | 2 |
| 1.228.200 Dengue | 0 | 0 | 1 | 1 | 2 |
| 1.228.994 Ebola Virus | 0 | 0 | 0 | 2 | 2 |
| 1.23.1036 Surgical Site Infection | 1 | 0 | 0 | 1 | 2 |
| 1.23.422 Gentamicin | 0 | 0 | 1 | 1 | 2 |
| 1.235.1679 Foreign Body | 0 | 0 | 0 | 2 | 2 |
| 1.258.1958 Leptospirosis | 0 | 0 | 0 | 2 | 2 |
| 1.286.845 Complement | 0 | 1 | 0 | 1 | 2 |
| 1.42.545 STEC | 0 | 0 | 0 | 2 | 2 |
| 1.6.351 Endotoxin | 0 | 0 | 1 | 1 | 2 |
| 1.81.1272 HLA-G | 0 | 0 | 0 | 2 | 2 |
| 1.81.1408 Fertility Preservation | 0 | 0 | 1 | 1 | 2 |
| 4.61.1124 Rough Sets | 0 | 0 | 1 | 1 | 2 |
| 6.178.516 Divorce | 0 | 0 | 0 | 2 | 2 |
| 1.100.1284 Fetal Alcohol Syndrome | 0 | 0 | 0 | 1 | 1 |
| 1.104.1770 Pertussis | 0 | 0 | 0 | 1 | 1 |
| 1.104.901 Foot-And-Mouth Disease Virus | 0 | 0 | 0 | 1 | 1 |
| 1.105.1677 Vertebral Artery Dissection | 0 | 0 | 1 | 0 | 1 |
| 1.111.162 Hepatocellular Carcinoma | 1 | 0 | 0 | 0 | 1 |
| 1.117.1309 Acetaminophen | 0 | 0 | 1 | 0 | 1 |
| 1.127.1303 Endothelin | 0 | 0 | 1 | 0 | 1 |
| 1.128.1489 Hysteroscopy | 0 | 0 | 0 | 1 | 1 |
| 1.128.1521 Ectopic Pregnancy | 0 | 0 | 0 | 1 | 1 |
| 1.132.2267 Clubfoot | 0 | 0 | 0 | 1 | 1 |
| 1.132.759 Matrix Metalloproteinases | 0 | 1 | 0 | 0 | 1 |
| 1.136.1749 Down Syndrome | 0 | 0 | 0 | 1 | 1 |
| 1.136.1780 Family Quality Of Life | 0 | 0 | 0 | 1 | 1 |
| 1.136.283 Autism | 0 | 0 | 0 | 1 | 1 |
| 1.14.1293 Emergency Department | 0 | 0 | 0 | 1 | 1 |
| 1.14.1359 Interprofessional Education | 0 | 0 | 0 | 1 | 1 |
| 1.142.1628 Urinary Diversion | 1 | 0 | 0 | 0 | 1 |
| 1.154.1088 Intensive Care | 0 | 0 | 0 | 1 | 1 |
| 1.154.277 Mechanical Ventilation | 0 | 0 | 0 | 1 | 1 |
| 1.155.598 Informed Consent | 0 | 0 | 0 | 1 | 1 |
| 1.158.2138 Porokeratosis | 0 | 0 | 0 | 1 | 1 |
| 1.163.446 Schistosomiasis | 0 | 0 | 0 | 1 | 1 |
| 1.164.1871 Menarche | 0 | 0 | 0 | 1 | 1 |
| 1.168.671 Vascular Access | 0 | 0 | 1 | 0 | 1 |
| 1.179.108 Human Papillomavirus | 0 | 0 | 0 | 1 | 1 |
| 1.184.1030 Erythropoietin | 1 | 0 | 0 | 0 | 1 |
| 1.184.653 Zinc | 0 | 0 | 0 | 1 | 1 |
| 1.186.1008 Nuchal Translucency | 0 | 0 | 0 | 1 | 1 |
| 1.186.948 Digeorge Syndrome | 0 | 0 | 0 | 1 | 1 |
| 1.195.1341 Enteric Nervous System | 1 | 0 | 0 | 0 | 1 |
| 1.199.1048 Pleurodesis | 1 | 0 | 0 | 0 | 1 |
| 1.213.168 Hypothyroidism | 0 | 0 | 1 | 0 | 1 |
| 1.216.2098 Intussusception | 0 | 1 | 0 | 0 | 1 |
| 1.217.1038 Toxoplasma Gondii | 0 | 0 | 1 | 0 | 1 |
| 1.225.1476 Alloimmunization | 0 | 0 | 0 | 1 | 1 |
| 1.225.786 Spectrin | 0 | 0 | 0 | 1 | 1 |
| 1.23.1397 Urinary Tract Infection | 0 | 0 | 0 | 1 | 1 |
| 1.23.714 Neisseria Meningitidis | 0 | 0 | 0 | 1 | 1 |
| 1.231.1650 Thiamine | 0 | 0 | 1 | 0 | 1 |
| 1.235.1617 Deglutition | 0 | 0 | 0 | 1 | 1 |
| 1.236.1155 Capsule Endoscopy | 0 | 0 | 1 | 0 | 1 |
| 1.236.312 Portal Hypertension | 0 | 0 | 0 | 1 | 1 |
| 1.243.1012 Vesicoureteral Reflux | 0 | 0 | 1 | 0 | 1 |
| 1.246.710 Rotavirus | 1 | 0 | 0 | 0 | 1 |
| 1.248.1683 Syphilis | 0 | 0 | 1 | 0 | 1 |
| 1.258.227 Lyme Disease | 0 | 0 | 1 | 0 | 1 |
| 1.26.107 Adiponectin | 0 | 0 | 0 | 1 | 1 |
| 1.26.337 Leptin | 0 | 1 | 0 | 0 | 1 |
| 1.261.596 Trypanosoma Cruzi | 0 | 1 | 0 | 0 | 1 |
| 1.266.1068 Pressure Ulcer | 0 | 0 | 0 | 1 | 1 |
| 1.278.1796 Neuroblastoma | 0 | 0 | 1 | 0 | 1 |
| 1.281.1236 Amyloidosis | 0 | 0 | 1 | 0 | 1 |
| 1.324.2020 Tetanus | 0 | 1 | 0 | 0 | 1 |
| 1.34.1657 Elbow | 0 | 0 | 1 | 0 | 1 |
| 1.36.2059 Retinopathy Of Prematurity | 0 | 0 | 0 | 1 | 1 |
| 1.37.467 Echocardiography | 0 | 0 | 1 | 0 | 1 |
| 1.49.1061 Endodontics | 0 | 0 | 0 | 1 | 1 |
| 1.5.1674 Ketogenic Diet | 0 | 1 | 0 | 0 | 1 |
| 1.5.420 Cortisol | 0 | 0 | 0 | 1 | 1 |
| 1.54.1401 Genome Editing | 0 | 0 | 1 | 0 | 1 |
| 1.54.958 HMGB1 | 0 | 1 | 0 | 0 | 1 |
| 1.55.1904 ACE Gene | 0 | 0 | 0 | 1 | 1 |
| 1.6.1437 Common Variable Immunodeficiency | 0 | 0 | 1 | 0 | 1 |
| 1.6.452 Somatic Hypermutation | 0 | 0 | 0 | 1 | 1 |
| 1.6.609 Toll-like Receptors | 0 | 0 | 0 | 1 | 1 |
| 1.65.192 COPD | 0 | 0 | 1 | 0 | 1 |
| 1.66.1615 Aids Dementia Complex | 0 | 0 | 0 | 1 | 1 |
| 1.68.256 Docosahexaenoic Acid | 0 | 0 | 0 | 1 | 1 |
| 1.68.707 Alpha-Tocopherol | 0 | 1 | 0 | 0 | 1 |
| 1.71.2048 Mean Platelet Volume | 0 | 0 | 0 | 1 | 1 |
| 1.72.1710 Postpartum Hemorrhage | 0 | 0 | 0 | 1 | 1 |
| 1.82.1298 Spinal Cord Injury Rehabilitation | 0 | 0 | 0 | 1 | 1 |
| 1.94.1664 VKORC1 | 1 | 0 | 0 | 0 | 1 |
| 1.95.387 Helicobacter Pylori | 0 | 0 | 0 | 1 | 1 |
| 1.95.801 Cimetidine | 0 | 0 | 1 | 0 | 1 |
| 3.16.1496 Ethnobotany | 0 | 0 | 0 | 1 | 1 |
| 3.171.1011 Carotenoids | 0 | 0 | 0 | 1 | 1 |
| 3.180.2418 Alginate Lyase | 0 | 0 | 0 | 1 | 1 |
| 3.198.400 Mycotoxins | 0 | 0 | 1 | 0 | 1 |
| 3.91.496 Cadmium | 0 | 0 | 0 | 1 | 1 |
| 6.146.734 Anthropology | 0 | 0 | 0 | 1 | 1 |
| 6.73.2331 Health Locus of Control | 0 | 0 | 0 | 1 | 1 |
| 8.124.1648 Heat Waves | 0 | 0 | 0 | 1 | 1 |
Table 4.
Values of the CNCI by topic. Note: for several topics, the number of articles is below 20.
| Micro-topic | CNCI (median) | ||||
|---|---|---|---|---|---|
| 2000–2004 | 2005–2009 | 2010–2014 | 2015–2019 | 2000–2019 | |
| 1.156.381 Maternal Mortality | 0.692 | 1.247 | 1.128 | 0.810 | 0.865 |
| 1.23.1757 Group B Streptococcus | 0.907 | 0.449 | 0.989 | 0.851 | 0.851 |
| 1.117.1389 Bilirubin | 1.034 | 1.129 | 1.127 | 0.900 | 1.034 |
| 1.72.182 Gestational Diabetes Mellitus | 0.509 | 0.571 | 0.856 | 1.219 | 0.885 |
| 1.72.924 Preterm Labor | 0.296 | 1.070 | 1.183 | 0.706 | 0.728 |
| 1.72.531 Preeclampsia | 0.561 | 0.832 | 0.528 | 0.732 | 0.650 |
| 1.66.11 HIV Prevalence & Prophylaxis | 1.747 | 0.387 | 0.713 | 1.182 | 1.105 |
| 1.217.59 Malaria | 0.155 | 0.732 | 1.123 | 0.879 | 1.012 |
| 1.72.922 Fetal Heart Rate | 0.514 | 2.879 | 0.883 | 0.775 | |
| 1.72.1732 Patent Ductus Arteriosus | 0.378 | 0.836 | 0.607 | 0.538 | 0.586 |
| 1.72.748 Preterm Infants | 0.355 | 0.203 | 0.808 | 0.724 | |
| 1.23.146 Antibiotic Resistance | 0.700 | 0.981 | 1.087 | 1.013 | |
| 1.216.2287 Gastroschisis | 0.716 | 1.595 | 0.488 | 0.551 | 0.605 |
| 1.44.1198 Food Insecurity | 1.291 | 1.044 | 1.246 | ||
| 1.72.808 Breech Presentation | 0.115 | 0.428 | 32.230 | 0.623 | 0.508 |
| 1.184.573 Iron Overload | 0.673 | 2.516 | 1.072 | 1.267 | 1.267 |
| 1.248.655 Chlamydia Trachomatis | 1.413 | 0.504 | 1.092 | 1.041 | |
| 1.72.891 Breastfeeding | 0.855 | 0.682 | 0.615 | 1.024 | 0.705 |
| 1.125.1718 Hepatitis E Virus | 0.731 | 3.131 | 0.561 | 0.981 | 0.981 |
| 1.72.1072 Postpartum Depression | 0.328 | 0.953 | 1.571 | 1.440 | |
| 1.80.279 Vitamin D | 2.210 | 0.611 | 0.611 | ||
| 1.225.2074 Methemoglobinemia | 0.923 | 0.893 | 0.893 | ||
| 1.49.468 Oral Health | 1.213 | 1.003 | 1.200 | ||
| 1.154.1057 Pulmonary Surfactant | 0.125 | 0.340 | 1.314 | 0.347 | 0.405 |
| 1.150.1148 Deaf | 0.854 | 0.262 | 0.690 | 0.769 | |
| 1.156.2047 Global Surgery | 0.383 | 1.792 | 1.760 | 1.084 | |
| 1.157.728 Biliary Atresia | 0.855 | 0.224 | 0.425 | 0.264 | 0.279 |
| 1.75.326 Antiphospholipid Syndrome | 1.917 | 0.560 | 0.297 | 0.600 | |
| 1.81.979 Twin-Twin Transfusion Syndrome | 0.299 | 0.739 | 0.000 | 0.279 | |
| 8.124.552 Air Pollution | 0.631 | 0.126 | 0.144 | ||
| 1.120.384 Gut Microbiota | 0.297 | 0.779 | 0.292 | ||
| 1.55.830 Acute Kidney Injury | 0.555 | 0.059 | 0.213 | ||
| 1.148.94 Candida Albicans | 0.408 | 1.067 | 0.782 | ||
| 1.151.222 Laparoscopic Cholecystectomy | 0.058 | 0.058 | |||
| 1.225.626 Sickle Cell Disease | 1.752 | 0.330 | 0.366 | ||
| 1.103.1225 ITP | 0.184 | 0.270 | 0.227 | ||
| 1.104.975 Respiratory Syncytial Virus | 0.000 | 2.082 | 0.951 | 0.951 | |
| 1.137.217 Melatonin | 0.526 | 0.526 | |||
| 1.154.360 Procalcitonin | 1.875 | 0.656 | 1.265 | ||
| 1.161.711 Cytomegalovirus | 0.067 | 2.382 | 0.057 | 0.095 | |
| 1.23.173 Staphylococcus Aureus | 0.487 | 0.487 | |||
| 1.42.678 Listeria Monocytogenes | 0.020 | 1.330 | 0.247 | 0.247 | |
| 1.82.1066 Cerebral Palsy | 0.667 | 0.741 | 0.704 | ||
| 1.104.126 Influenza | 0.225 | 4.503 | 0.323 | ||
| 1.125.275 HBV | 0.086 | 0.086 | |||
| 1.128.482 Contraception | 0.273 | 0.273 | |||
| 1.194.273 Mycobacterium Tuberculosis & Leprosy | 14.577 | 0.506 | 0.757 | ||
| 1.216.1563 Volvulus | 1.147 | 1.147 | |||
| 1.216.1996 Pneumomediastinum | 0.000 | 0.940 | 0.266 | ||
| 1.222.143 Epilepsy | 0.411 | 2.051 | 0.505 | 0.505 | |
| 1.231.432 Homocysteine | 0.625 | 0.782 | 1.378 | 0.782 | |
| 1.248.1317 Mycoplasma | 1.097 | 0.413 | 0.524 | ||
| 1.248.2104 Trichomonas Vaginalis | 2.165 | 0.828 | 0.983 | 0.983 | |
| 1.257.983 Hydrocephalus | 2.215 | 0.473 | 1.570 | ||
| 1.37.309 Congenital Heart Disease | 1.896 | 1.470 | 1.896 | ||
| 1.72.1745 Hyperemesis Gravidarum | 0.473 | 0.376 | 0.376 | ||
| 1.95.723 Irritable Bowel Syndrome | 0.389 | 1.004 | 0.721 | ||
| 3.91.920 Selenium | 0.590 | 0.190 | 0.260 | ||
| 6.24.858 Intimate Partner Violence | 2.078 | 5.989 | 4.888 | ||
| 1.125.83 HCV | 0.546 | 1.320 | 0.933 | ||
| 1.141.407 Acute Promyelocytic Leukemia | 0.278 | 2.227 | 1.253 | ||
| 1.142.832 Fecal Incontinence | 0.231 | 2.110 | 1.171 | ||
| 1.161.315 HSV-1 | 0.625 | 0.625 | |||
| 1.228.200 Dengue | 0.273 | 1.134 | 0.703 | ||
| 1.228.994 Ebola Virus | 0.330 | 0.330 | |||
| 1.23.1036 Surgical Site Infection | 0.387 | 0.324 | 0.355 | ||
| 1.23.422 Gentamicin | 0.628 | 0.401 | 0.514 | ||
| 1.235.1679 Foreign Body | 0.471 | 0.471 | |||
| 1.258.1958 Leptospirosis | 0.373 | 0.373 | |||
| 1.286.845 Complement | 0.193 | 0.384 | 0.288 | ||
| 1.42.545 STEC | 0.605 | 0.605 | |||
| 1.6.351 Endotoxin | 0.890 | 0.936 | 0.913 | ||
| 1.81.1272 HLA-G | 0.554 | 0.554 | |||
| 1.81.1408 Fertility Preservation | 1.008 | 0.111 | 0.559 | ||
| 4.61.1124 Rough Sets | 0.966 | 0.589 | 0.777 | ||
| 6.178.516 Divorce | 2.074 | 2.074 | |||
| 1.100.1284 Fetal Alcohol Syndrome | 1.536 | 1.536 | |||
| 1.104.1770 Pertussis | 0.924 | 0.924 | |||
| 1.104.901 Foot-And-Mouth Disease Virus | 1.438 | 1.438 | |||
| 1.105.1677 Vertebral Artery Dissection | 0.978 | 0.978 | |||
| 1.111.162 Hepatocellular Carcinoma | 0.197 | 0.197 | |||
| 1.117.1309 Acetaminophen | 0.178 | 0.178 | |||
| 1.127.1303 Endothelin | 0.810 | 0.810 | |||
| 1.128.1489 Hysteroscopy | 0.287 | 0.287 | |||
| 1.128.1521 Ectopic Pregnancy | 3.365 | 3.365 | |||
| 1.132.2267 Clubfoot | 1.649 | 1.649 | |||
| 1.132.759 Matrix Metalloproteinases | 1.198 | 1.198 | |||
| 1.136.1749 Down Syndrome | 0.225 | 0.225 | |||
| 1.136.1780 Family Quality Of Life | 0.931 | 0.931 | |||
| 1.136.283 Autism | 0.301 | 0.301 | |||
| 1.14.1293 Emergency Department | 0.192 | 0.192 | |||
| 1.14.1359 Interprofessional Education | 0.637 | 0.637 | |||
| 1.142.1628 Urinary Diversion | 0.965 | 0.965 | |||
| 1.154.1088 Intensive Care | 0.144 | 0.144 | |||
| 1.154.277 Mechanical Ventilation | 0.037 | 0.037 | |||
| 1.155.598 Informed Consent | 0.495 | 0.495 | |||
| 1.158.2138 Porokeratosis | 1.291 | 1.291 | |||
| 1.163.446 Schistosomiasis | 2.650 | 2.650 | |||
| 1.164.1871 Menarche | 0.271 | 0.271 | |||
| 1.168.671 Vascular Access | 0.337 | 0.337 | |||
| 1.179.108 Human Papillomavirus | 0.776 | 0.776 | |||
| 1.184.1030 Erythropoietin | 0.056 | 0.056 | |||
| 1.184.653 Zinc | 1.264 | 1.264 | |||
| 1.186.1008 Nuchal Translucency | 1.270 | 1.270 | |||
| 1.186.948 Digeorge Syndrome | 0.070 | 0.070 | |||
| 1.195.1341 Enteric Nervous System | 0.590 | 0.590 | |||
| 1.199.1048 Pleurodesis | 0.857 | 0.857 | |||
| 1.213.168 Hypothyroidism | 0.000 | 0.000 | |||
| 1.216.2098 Intussusception | 0.134 | 0.134 | |||
| 1.217.1038 Toxoplasma Gondii | 0.755 | 0.755 | |||
| 1.225.1476 Alloimmunization | 0.492 | 0.492 | |||
| 1.225.786 Spectrin | 0.000 | 0.000 | |||
| 1.23.1397 Urinary Tract Infection | 0.704 | 0.704 | |||
| 1.23.714 Neisseria Meningitidis | 0.000 | 0.000 | |||
| 1.231.1650 Thiamine | 0.447 | 0.447 | |||
| 1.235.1617 Deglutition | 0.324 | 0.324 | |||
| 1.236.1155 Capsule Endoscopy | 0.325 | 0.325 | |||
| 1.236.312 Portal Hypertension | 0.000 | 0.000 | |||
| 1.243.1012 Vesicoureteral Reflux | 0.621 | 0.621 | |||
| 1.246.710 Rotavirus | 0.620 | 0.620 | |||
| 1.248.1683 Syphilis | 0.597 | 0.597 | |||
| 1.258.227 Lyme Disease | 3.590 | 3.590 | |||
| 1.26.107 Adiponectin | 0.631 | 0.631 | |||
| 1.26.337 Leptin | 0.794 | 0.794 | |||
| 1.261.596 Trypanosoma Cruzi | 0.286 | 0.286 | |||
| 1.266.1068 Pressure Ulcer | 1.124 | 1.124 | |||
| 1.278.1796 Neuroblastoma | 0.057 | 0.057 | |||
| 1.281.1236 Amyloidosis | 0.816 | 0.816 | |||
| 1.324.2020 Tetanus | 0.766 | 0.766 | |||
| 1.34.1657 Elbow | 0.071 | 0.071 | |||
| 1.36.2059 Retinopathy Of Prematurity | 0.599 | 0.599 | |||
| 1.37.467 Echocardiography | 0.380 | 0.380 | |||
| 1.49.1061 Endodontics | 1.046 | 1.046 | |||
| 1.5.1674 Ketogenic Diet | 0.000 | 0.000 | |||
| 1.5.420 Cortisol | 1.267 | 1.267 | |||
| 1.54.1401 Genome Editing | 0.923 | 0.923 | |||
| 1.54.958 HMGB1 | 0.784 | 0.784 | |||
| 1.55.1904 ACE Gene | 0.229 | 0.229 | |||
| 1.6.1437 Common Variable Immunodeficiency | 0.349 | 0.349 | |||
| 1.6.452 Somatic Hypermutation | 0.000 | 0.000 | |||
| 1.6.609 Toll-like Receptors | 0.165 | 0.165 | |||
| 1.65.192 COPD | 187.114 | 187.114 | |||
| 1.66.1615 Aids Dementia Complex | 4.164 | 4.164 | |||
| 1.68.256 Docosahexaenoic Acid | 0.625 | 0.625 | |||
| 1.68.707 Alpha-Tocopherol | 1.361 | 1.361 | |||
| 1.71.2048 Mean Platelet Volume | 0.405 | 0.405 | |||
| 1.72.1710 Postpartum Hemorrhage | 0.000 | 0.000 | |||
| 1.82.1298 Spinal Cord Injury Rehabilitation | 3.041 | 3.041 | |||
| 1.94.1664 VKORC1 | 0.081 | 0.081 | |||
| 1.95.387 Helicobacter Pylori | 0.466 | 0.466 | |||
| 1.95.801 Cimetidine | 0.233 | 0.233 | |||
| 3.16.1496 Ethnobotany | 0.658 | 0.658 | |||
| 3.171.1011 Carotenoids | 0.531 | 0.531 | |||
| 3.180.2418 Alginate Lyase | 0.425 | 0.425 | |||
| 3.198.400 Mycotoxins | 3.158 | 3.158 | |||
| 3.91.496 Cadmium | 0.000 | 0.000 | |||
| 6.146.734 Anthropology | 2.034 | 2.034 | |||
| 6.73.2331 Health Locus of Control | 2.211 | 2.211 | |||
| 8.124.1648 Heat Waves | 0.666 | 0.666 | |||
Collaboration
Table 5.
The number and percentage of articles by type of collaboration and period of publication.
| Period | Collaboration | |||||
|---|---|---|---|---|---|---|
| DRC (nº) | IRC (nº) | no_coll (nº) | DRC (%) | IRC (%) | no_coll(%) | |
| 2000–2019 | 555 | 669 | 26 | 44.4 | 53.5 | 2.1 |
| 2000–2004 | 32 | 17 | 6 | 58.2 | 30.9 | 10.9 |
| 2005–2009 | 57 | 67 | 1 | 45.6 | 53.6 | 0.8 |
| 2010–2014 | 122 | 179 | 11 | 39.1 | 57.4 | 3.5 |
| 2015–2019 | 344 | 406 | 8 | 45.4 | 53.6 | 1.1 |
| Period | IRCintra(nº) | IRCinter(nº) | IRCinter_intra (nº) | IRCintra(%) | IRCinter(%) | IRCinter_intra (%) |
| 2000–2019 | 19 | 541 | 109 | 2.8 | 80.9 | 16.3 |
| 2000–2004 | 0 | 15 | 2 | 0.0 | 88.2 | 11.8 |
| 2005–2009 | 1 | 60 | 6 | 1.5 | 89.6 | 9.0 |
| 2010–2014 | 2 | 151 | 26 | 1.1 | 84.4 | 14.5 |
| 2015–2019 | 16 | 315 | 75 | 3.9 | 77.6 | 18.5 |
Table 6.
Number of articles with DRC by African country.
| Country | Pub (nº) | ||||
|---|---|---|---|---|---|
| 2000–2019 | 2000–2004 | 2005–2009 | 2010–2014 | 2015–2019 | |
| EGYPT | 167 | 2 | 9 | 38 | 118 |
| NIGERIA | 116 | 7 | 22 | 32 | 55 |
| SOUTH AFRICA | 107 | 15 | 15 | 19 | 58 |
| ETHIOPIA | 51 | 0 | 0 | 2 | 49 |
| TUNISIA | 18 | 2 | 4 | 4 | 8 |
| MOROCCO | 14 | 0 | 0 | 8 | 6 |
| CAMEROON | 11 | 0 | 0 | 5 | 6 |
| TANZANIA | 11 | 1 | 1 | 3 | 6 |
| GHANA | 11 | 1 | 2 | 0 | 8 |
| SUDAN | 9 | 1 | 1 | 3 | 4 |
| SENEGAL | 7 | 1 | 0 | 2 | 4 |
| UGANDA | 6 | 0 | 0 | 1 | 5 |
| KENYA | 6 | 1 | 0 | 1 | 4 |
| BENIN | 3 | 0 | 0 | 1 | 2 |
| TOGO | 2 | 0 | 1 | 0 | 1 |
| MALI | 2 | 0 | 0 | 2 | 0 |
| BURKINA FASO | 2 | 0 | 0 | 0 | 2 |
| ZIMBABWE | 2 | 0 | 0 | 1 | 1 |
| MADAGASCAR | 2 | 0 | 0 | 0 | 2 |
| CONGO DEMOCRATIC REPUBLIC | 2 | 0 | 0 | 0 | 2 |
| MALAWI | 2 | 0 | 1 | 0 | 1 |
| ERITREA | 1 | 0 | 1 | 0 | 0 |
| NIGER | 1 | 0 | 0 | 0 | 1 |
| ALGERIA | 1 | 1 | 0 | 0 | 0 |
| GABON | 1 | 0 | 0 | 0 | 1 |
Table 7.
The number of articles with the collaboration of scientists from non-African countries.
| Country | Pub (nº) | ||||
|---|---|---|---|---|---|
| 2000–2019 | 2000–2004 | 2005–2009 | 2010–2014 | 2015–2019 | |
| USA | 384 | 8 | 34 | 110 | 232 |
| UK | 188 | 3 | 22 | 46 | 117 |
| India | 63 | 0 | 5 | 17 | 41 |
| Australia | 55 | 2 | 5 | 10 | 38 |
| Switzerland | 52 | 3 | 4 | 13 | 32 |
| Canada | 51 | 0 | 1 | 8 | 42 |
| Pakistan | 51 | 0 | 2 | 17 | 32 |
| France | 47 | 0 | 7 | 15 | 25 |
| The Netherlands | 43 | 0 | 4 | 9 | 30 |
| Norway | 42 | 1 | 2 | 13 | 26 |
| Finland | 33 | 1 | 0 | 5 | 27 |
| Germany | 33 | 1 | 2 | 7 | 23 |
| Brazil | 32 | 0 | 0 | 14 | 18 |
| Sweden | 32 | 2 | 3 | 11 | 16 |
| Belgium | 32 | 1 | 0 | 9 | 22 |
| Spain | 24 | 0 | 0 | 5 | 19 |
| Bangladesh | 22 | 0 | 3 | 3 | 16 |
| Denmark | 22 | 0 | 0 | 6 | 16 |
| China | 21 | 0 | 0 | 8 | 13 |
| Argentina | 21 | 0 | 1 | 4 | 16 |
| Italy | 20 | 0 | 0 | 6 | 14 |
| Saudi Arabia | 15 | 0 | 0 | 4 | 11 |
| Guatemala | 15 | 0 | 0 | 3 | 12 |
| Thailand | 13 | 0 | 0 | 4 | 9 |
| Singapore | 10 | 0 | 0 | 2 | 8 |
| Japan | 10 | 0 | 1 | 5 | 4 |
| Nepal | 9 | 0 | 0 | 1 | 8 |
| Indonesia | 8 | 0 | 1 | 0 | 7 |
| Vietnam | 8 | 0 | 1 | 1 | 6 |
| Austria | 8 | 0 | 0 | 2 | 6 |
| Chile | 7 | 0 | 0 | 3 | 4 |
| Philippines | 7 | 2 | 0 | 0 | 5 |
| Mexico | 7 | 0 | 0 | 1 | 6 |
| New Zealand | 7 | 0 | 0 | 1 | 6 |
| Oman | 7 | 0 | 0 | 4 | 3 |
| Turkey | 7 | 0 | 0 | 1 | 6 |
| Malaysia | 6 | 0 | 0 | 1 | 5 |
| Israel | 6 | 0 | 1 | 2 | 3 |
| Peru | 5 | 0 | 1 | 0 | 4 |
| Ireland | 5 | 0 | 0 | 1 | 4 |
| United Arab Emirates | 5 | 0 | 0 | 1 | 4 |
| Jordan | 4 | 0 | 0 | 0 | 4 |
| Russia | 4 | 0 | 0 | 1 | 3 |
| Colombia | 4 | 0 | 0 | 0 | 4 |
| Lebanon | 4 | 0 | 1 | 0 | 3 |
| South Korea | 4 | 0 | 0 | 0 | 4 |
| Portugal | 4 | 0 | 0 | 0 | 4 |
| Czechia | 4 | 0 | 2 | 1 | 1 |
| Bolivia | 4 | 0 | 1 | 1 | 2 |
| Costa Rica | 3 | 0 | 0 | 0 | 3 |
| Bahrain | 3 | 0 | 0 | 0 | 3 |
| Greece | 3 | 0 | 0 | 0 | 3 |
| Poland | 3 | 0 | 0 | 0 | 3 |
| Iran | 3 | 0 | 0 | 0 | 3 |
| Serbia | 3 | 0 | 0 | 0 | 3 |
| Papua New Guinea | 3 | 1 | 0 | 0 | 2 |
| Romania | 3 | 0 | 0 | 0 | 3 |
| Luxembourg | 3 | 0 | 0 | 0 | 3 |
| Slovakia | 3 | 0 | 0 | 0 | 3 |
| Uruguay | 3 | 0 | 0 | 1 | 2 |
| Qatar | 3 | 0 | 0 | 0 | 3 |
| Sri Lanka | 3 | 0 | 0 | 1 | 2 |
| Kyrgyzstan | 3 | 0 | 0 | 0 | 3 |
| Croatia | 3 | 0 | 1 | 1 | 1 |
| Lithuania | 3 | 0 | 0 | 0 | 3 |
| Cambodia | 3 | 0 | 0 | 1 | 2 |
| Micronesia | 2 | 0 | 0 | 0 | 2 |
| Iceland | 2 | 0 | 0 | 0 | 2 |
| Iraq | 2 | 0 | 0 | 0 | 2 |
| Estonia | 2 | 0 | 0 | 0 | 2 |
| Ukraine | 2 | 0 | 0 | 0 | 2 |
| Georgia | 2 | 0 | 0 | 0 | 2 |
| Panama | 2 | 0 | 0 | 1 | 1 |
| Slovenia | 2 | 0 | 0 | 0 | 2 |
| Myanmar | 1 | 0 | 0 | 0 | 1 |
| Bhutan | 1 | 0 | 0 | 0 | 1 |
| Yemen | 1 | 0 | 0 | 0 | 1 |
| Kazakhstan | 1 | 0 | 0 | 0 | 1 |
| Jamaica | 1 | 0 | 0 | 1 | 0 |
| Albania | 1 | 0 | 0 | 0 | 1 |
| Malta | 1 | 0 | 0 | 0 | 1 |
| Latvia | 1 | 0 | 0 | 0 | 1 |
| Armenia | 1 | 0 | 0 | 0 | 1 |
| Bosnia and Herzegovina | 1 | 0 | 0 | 0 | 1 |
| North Macedonia | 1 | 0 | 0 | 0 | 1 |
| Montenegro | 1 | 0 | 0 | 0 | 1 |
| Hungary | 1 | 0 | 0 | 0 | 1 |
| Syria | 1 | 0 | 0 | 0 | 1 |
| Haiti | 1 | 0 | 0 | 0 | 1 |
Table 8.
Statistics for the countries in the collaboration network representing the whole period.
| Country | Degree | Eigencentrality |
|---|---|---|
| Algeria | 92 | 0.901 |
| Angola | 84 | 0.836 |
| Benin | 93 | 0.904 |
| Botswana | 5 | 0.038 |
| Burkina Faso | 36 | 0.338 |
| Burundi | 76 | 0.746 |
| Cameroon | 92 | 0.901 |
| Central African Republic | 6 | 0.059 |
| Chad | 11 | 0.106 |
| Congo | 5 | 0.051 |
| Cote Ivoire | 87 | 0.844 |
| Democratic Republic of the Congo | 82 | 0.776 |
| Egypt | 101 | 0.935 |
| Ethiopia | 93 | 0.906 |
| Gabon | 29 | 0.276 |
| Gambia | 89 | 0.852 |
| Ghana | 112 | 0.986 |
| Guinea-Bissau | 28 | 0.267 |
| Kenya | 101 | 0.932 |
| Liberia | 1 | 0.011 |
| Libya | 29 | 0.270 |
| Madagascar | 5 | 0.034 |
| Malawi | 47 | 0.423 |
| Mali | 8 | 0.077 |
| Morocco | 85 | 0.844 |
| Mozambique | 82 | 0.799 |
| Niger | 2 | 0.021 |
| Nigeria | 113 | 0.987 |
| Rwanda | 99 | 0.923 |
| Senegal | 25 | 0.219 |
| Sierra Leone | 27 | 0.250 |
| South Africa | 115 | 0.983 |
| South Sudan | 5 | 0.047 |
| Sudan | 49 | 0.439 |
| Tanzania | 103 | 0.944 |
| Togo | 84 | 0.836 |
| Tunisia | 84 | 0.836 |
| Uganda | 100 | 0.928 |
| Zambia | 101 | 0.934 |
| Zimbabwe | 92 | 0.873 |
| Albania | 47 | 0.433 |
| Argentina | 100 | 0.916 |
| Armenia | 47 | 0.433 |
| Australia | 112 | 0.981 |
| Austria | 87 | 0.848 |
| Bahrain | 103 | 0.955 |
| Bangladesh | 108 | 0.956 |
| Belgium | 112 | 0.983 |
| Bhutan | 74 | 0.736 |
| Bolivia | 45 | 0.425 |
| Bosnia and Herzegovina | 47 | 0.433 |
| Brazil | 111 | 0.975 |
| Cambodia | 5 | 0.033 |
| Canada | 114 | 0.992 |
| Chile | 104 | 0.960 |
| China | 114 | 0.992 |
| Colombia | 92 | 0.901 |
| Costa Rica | 103 | 0.955 |
| Croatia | 48 | 0.443 |
| Czechia | 11 | 0.113 |
| Denmark | 101 | 0.936 |
| Estonia | 92 | 0.901 |
| Finland | 107 | 0.969 |
| France | 104 | 0.929 |
| Georgia | 96 | 0.898 |
| Germany | 109 | 0.977 |
| Greece | 103 | 0.955 |
| Guatemala | 10 | 0.099 |
| Haiti | 4 | 0.028 |
| Hungary | 27 | 0.258 |
| Iceland | 92 | 0.901 |
| India | 117 | 0.996 |
| Indonesia | 101 | 0.931 |
| Iran | 103 | 0.955 |
| Iraq | 92 | 0.901 |
| Ireland | 104 | 0.960 |
| Israel | 100 | 0.921 |
| Italy | 108 | 0.973 |
| Jamaica | 4 | 0.042 |
| Japan | 104 | 0.960 |
| Jordan | 108 | 0.973 |
| Kazakhstan | 74 | 0.736 |
| Kyrgyzstan | 89 | 0.829 |
| Latvia | 47 | 0.433 |
| Lebanon | 92 | 0.901 |
| Lithuania | 60 | 0.524 |
| Luxembourg | 92 | 0.901 |
| Malaysia | 99 | 0.928 |
| Malta | 47 | 0.433 |
| Mexico | 112 | 0.986 |
| Micronesia | 92 | 0.901 |
| Montenegro | 47 | 0.433 |
| Myanmar | 84 | 0.836 |
| Nepal | 87 | 0.820 |
| Netherlands | 113 | 0.985 |
| New Zealand | 93 | 0.906 |
| North Macedonia | 47 | 0.433 |
| Norway | 97 | 0.922 |
| Oman | 84 | 0.836 |
| Pakistan | 116 | 0.994 |
| Panama | 87 | 0.857 |
| Papua New Guinea | 92 | 0.901 |
| Peru | 92 | 0.901 |
| Philippines | 93 | 0.907 |
| Poland | 103 | 0.955 |
| Portugal | 93 | 0.904 |
| Qatar | 85 | 0.837 |
| Romania | 98 | 0.925 |
| Russia | 104 | 0.960 |
| Saudi Arabia | 105 | 0.964 |
| Serbia | 103 | 0.955 |
| Singapore | 109 | 0.977 |
| Slovakia | 92 | 0.901 |
| Slovenia | 48 | 0.442 |
| South Korea | 94 | 0.907 |
| Spain | 112 | 0.982 |
| Sri Lanka | 88 | 0.863 |
| Sweden | 105 | 0.945 |
| Switzerland | 112 | 0.981 |
| Syria | 27 | 0.250 |
| Thailand | 64 | 0.559 |
| Turkey | 106 | 0.943 |
| UK | 119 | 0.997 |
| Ukraine | 92 | 0.901 |
| United Arab Emirates | 94 | 0.909 |
| Uruguay | 88 | 0.858 |
| USA | 125 | 1.000 |
| Vietnam | 94 | 0.908 |
| Yemen | 74 | 0.736 |
Table 9.
Number of universities by country for the whole period.
| Country | Universities (nº) | Country | Universities (nº) |
|---|---|---|---|
| USA | 116 | Serbia | 3 |
| UK | 30 | Singapore | 3 |
| Australia | 26 | United Arab Emirates | 3 |
| Nigeria | 23 | Algeria | 2 |
| China | 21 | Burkina Faso | 2 |
| Ethiopia | 20 | Cameroon | 2 |
| Canada | 19 | Cote Ivoire | 2 |
| Egypt | 16 | Guatemala | 2 |
| India | 16 | Indonesia | 2 |
| Iran | 16 | Ireland | 2 |
| Germany | 15 | Jordan | 2 |
| Italy | 15 | Lebanon | 2 |
| Brazil | 14 | Lithuania | 2 |
| France | 12 | Malawi | 2 |
| South Africa | 12 | Nepal | 2 |
| Saudi Arabia | 11 | Romania | 2 |
| Japan | 10 | Slovakia | 2 |
| Spain | 10 | Sri Lanka | 2 |
| Kenya | 9 | Zambia | 2 |
| Netherlands | 9 | Albania | 1 |
| Tanzania | 9 | Bahrain | 1 |
| Malaysia | 7 | Benin | 1 |
| Sweden | 7 | Botswana | 1 |
| Belgium | 6 | Costa Rica | 1 |
| Pakistan | 6 | Croatia | 1 |
| South Korea | 6 | Czechia | 1 |
| Sudan | 6 | Estonia | 1 |
| Ghana | 5 | Gabon | 1 |
| Philippines | 5 | Georgia | 1 |
| Portugal | 5 | Greece | 1 |
| Switzerland | 5 | Iceland | 1 |
| Turkey | 5 | Israel | 1 |
| Uganda | 5 | Jamaica | 1 |
| Vietnam | 5 | Kazakhstan | 1 |
| Bangladesh | 4 | Latvia | 1 |
| Chile | 4 | Madagascar | 1 |
| Colombia | 4 | Mali | 1 |
| Denmark | 4 | Mexico | 1 |
| Finland | 4 | Morocco | 1 |
| New Zealand | 4 | Mozambique | 1 |
| Norway | 4 | Papua New Guinea | 1 |
| Thailand | 4 | Qatar | 1 |
| Tunisia | 4 | Rwanda | 1 |
| Austria | 3 | Sierra Leone | 1 |
| Dem. Republic of the Congo | 3 | Slovenia | 1 |
| Iraq | 3 | Syria | 1 |
| Libya | 3 | Togo | 1 |
| Poland | 3 | Uruguay | 1 |
| Russia | 3 | Zimbabwe | 1 |
Table 10.
The total number of universities by region, period and respective representativity given the total number of universities in each period.
Table 10.
The total number of universities by region, period and respective representativity given the total number of universities in each period.
| Period | African (nº) | Non-African (nº) | African (%) | Non-African (%) |
|---|---|---|---|---|
| 2000–2019 | 138 | 489 | 22 | 78 |
| 2000–2004 | 8 | 11 | 42 | 58 |
| 2005–2009 | 25 | 52 | 32 | 68 |
| 2010–2014 | 60 | 161 | 27 | 73 |
| 2015–2019 | 126 | 446 | 22 | 78 |
Collaboration Networks
Figure 5.
Collaboration network given the countries involved in IRC representing the whole period. Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 5059 links. The grey links represent publications between non-African countries, the pink links between African and non-African countries, and the blue links between African countries.
Figure 5.
Collaboration network given the countries involved in IRC representing the whole period. Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 5059 links. The grey links represent publications between non-African countries, the pink links between African and non-African countries, and the blue links between African countries.

Figure 6.
Collaboration subnetwork between African and non-African countries in 2000–2019 (the subnetwork derived from Figure 5). Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 1834 links.
Figure 6.
Collaboration subnetwork between African and non-African countries in 2000–2019 (the subnetwork derived from Figure 5). Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 1834 links.

Figure 7.
Collaboration subnetwork between African and non-African countries where each link represents two or more publications (the subnetwork derived from Figure 5). Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 942 links.
Figure 7.
Collaboration subnetwork between African and non-African countries where each link represents two or more publications (the subnetwork derived from Figure 5). Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 942 links.

Figure 8.
Collaboration network between universities representing the whole period. The high number of universities does not allow organizing the network in a way that it is possible to identify the university represented in each node. Therefore, the universities are not labelled. Blue nodes represent African universities and grey non-African universities. This network has 627 nodes and 48468 links. The grey links represent publications between non-African universities, the pink links between African and non-African universities, and the blue and green links between African universities.
Figure 8.
Collaboration network between universities representing the whole period. The high number of universities does not allow organizing the network in a way that it is possible to identify the university represented in each node. Therefore, the universities are not labelled. Blue nodes represent African universities and grey non-African universities. This network has 627 nodes and 48468 links. The grey links represent publications between non-African universities, the pink links between African and non-African universities, and the blue and green links between African universities.

Figure 9.
Collaboration subnetwork between African universities (the subnetwork derived from Figure 8). The subnetwork has 138 nodes and 804 links.
Figure 9.
Collaboration subnetwork between African universities (the subnetwork derived from Figure 8). The subnetwork has 138 nodes and 804 links.

Figure 10.
Collaboration subnetwork between African and non-African universities (the subnetwork derived from Figure 8). The subnetwork has 627 nodes and 10409 links.
Figure 10.
Collaboration subnetwork between African and non-African universities (the subnetwork derived from Figure 8). The subnetwork has 627 nodes and 10409 links.

Table 11.
Statistics for the universities in the collaboration network for the whole period.
| University | Degree | Eigencentrality |
|---|---|---|
| AAU-DNK | 316 | 0.969 |
| AAU-ETH | 319 | 0.970 |
| ABU-NGA | 346 | 0.978 |
| ABZUMS-IRN | 316 | 0.969 |
| ACU-AUS | 258 | 0.828 |
| AGU-BHR | 316 | 0.969 |
| AGU-ETH | 6 | 0.009 |
| AI-Azar-EGY | 2 | 0.000 |
| AKU-KEN | 267 | 0.833 |
| AKU-PAK | 324 | 0.850 |
| AKU-TZA | 3 | 0.006 |
| Al Neelain-SDN | 3 | 0.000 |
| ALEPUNIV-SYR | 22 | 0.046 |
| Al-Zahar-EGY | 4 | 0.000 |
| AMU-ETH | 258 | 0.828 |
| ANSU-NGA | 2 | 0.003 |
| ANU-AUS | 316 | 0.969 |
| ARU-GBR | 316 | 0.969 |
| ASE-ROM | 221 | 0.695 |
| ASU-EGY | 15 | 0.027 |
| ASU-JOR | 41 | 0.059 |
| ASU-System-USA | 258 | 0.828 |
| Ateneo-PHL | 316 | 0.969 |
| ATSU-USA | 221 | 0.695 |
| AU-AUS | 318 | 0.970 |
| AU-DNK | 221 | 0.695 |
| AU-EGY | 4 | 0.007 |
| AU-ETH | 221 | 0.695 |
| AU-IND | 41 | 0.059 |
| AUMS-IRN | 258 | 0.828 |
| AUN-EGY | 24 | 0.046 |
| AU-SAU | 316 | 0.969 |
| AUT-NZL | 331 | 0.978 |
| AUW-SDN | 1 | 0.003 |
| AYBU-TUR | 36 | 0.065 |
| BCMS-IRQ | 258 | 0.828 |
| BCM-USA | 335 | 0.979 |
| BDU-ETH | 318 | 0.970 |
| BFUHS-IND | 258 | 0.828 |
| BHU-IND | 258 | 0.828 |
| BLDE Univ-IND | 16 | 0.012 |
| BMSU-IRN | 316 | 0.969 |
| BSMMU-BGD | 16 | 0.012 |
| BSMS-GBR | 318 | 0.970 |
| BSU-EGY | 3 | 0.000 |
| BSU-FRA | 2 | 0.004 |
| BSU-USA | 221 | 0.695 |
| BU-EGY | 1 | 0.000 |
| BU-GBR | 27 | 0.053 |
| BU-IND | 2 | 0.004 |
| BUK-NGA | 4 | 0.007 |
| BU-MLI | 4 | 0.007 |
| BU-NGA | 1 | 0.000 |
| BU-UGA | 3 | 0.007 |
| BU-USA | 287 | 0.854 |
| BYU-USA | 278 | 0.850 |
| Cal State-USA | 1 | 0.003 |
| CAM-GBR | 270 | 0.830 |
| CCMU-CHN | 127 | 0.243 |
| CDartmouth-USA | 326 | 0.972 |
| CDU-AUS | 60 | 0.148 |
| CDU-USA | 258 | 0.828 |
| CEU-UCH-ESP | 316 | 0.969 |
| CMU-CHN | 9 | 0.017 |
| CMU-THA | 3 | 0.007 |
| COSECSA-TZA | 1 | 0.000 |
| CPUT-ZAF | 1 | 0.000 |
| CQMU-CHN | 41 | 0.059 |
| CSPH-PAK | 316 | 0.969 |
| CSU-CHN | 258 | 0.828 |
| CTUMP-VNM | 1 | 0.003 |
| CU-CZE | 15 | 0.025 |
| CU-EGY | 339 | 0.973 |
| CUHAS-TZA | 9 | 0.013 |
| CUNY-USA | 258 | 0.828 |
| CUSM-USA | 15 | 0.025 |
| CU-System-USA | 273 | 0.834 |
| CU-THA | 41 | 0.059 |
| CU-USA | 366 | 0.987 |
| CWRU-USA | 318 | 0.970 |
| Dal-CAN | 282 | 0.843 |
| DBU-ETH | 316 | 0.969 |
| DELSU-NGA | 3 | 0.004 |
| DHSC-ETH | 1 | 0.002 |
| DKU-CHN | 258 | 0.828 |
| DMU-ETH | 316 | 0.969 |
| DTU-VNM | 316 | 0.969 |
| DU-AUS | 246 | 0.734 |
| DU-BGD | 50 | 0.070 |
| DU-ETH | 221 | 0.695 |
| DU-GBR | 3 | 0.010 |
| DU-IND | 321 | 0.971 |
| Duke-NUS-SGP | 260 | 0.829 |
| DU-SWE | 316 | 0.969 |
| DUT-ZAF | 258 | 0.828 |
| DU-USA | 7 | 0.011 |
| ECU-AUS | 39 | 0.069 |
| EDU-ETH | 5 | 0.006 |
| Einstein-USA | 267 | 0.830 |
| ENS-ESP | 221 | 0.695 |
| ENSV-DZA | 221 | 0.695 |
| ESUT-NGA | 2 | 0.003 |
| EU-GBR | 3 | 0.004 |
| EU-KEN | 10 | 0.021 |
| EUR-NLD | 331 | 0.978 |
| EU-USA | 343 | 0.982 |
| EVMS-USA | 15 | 0.025 |
| FDU-CHN | 342 | 0.977 |
| FHU-JPN | 3 | 0.004 |
| FOM-DEU | 258 | 0.828 |
| FU-AUS | 331 | 0.978 |
| GMU-USA | 331 | 0.978 |
| GOUMS-IRN | 316 | 0.969 |
| GU-AUS | 335 | 0.980 |
| GU-SDN | 2 | 0.000 |
| GU-SWE | 316 | 0.969 |
| GU-USA | 320 | 0.970 |
| GWU-USA | 269 | 0.834 |
| HBMSU-ARE | 316 | 0.969 |
| HHU-DEU | 1 | 0.000 |
| HKU-CHN | 278 | 0.850 |
| HMU-VNM | 316 | 0.969 |
| HSE Univ-RUS | 258 | 0.828 |
| HU-EGY | 8 | 0.011 |
| HU-ETH | 316 | 0.969 |
| HUJI-ISR | 60 | 0.150 |
| HUST-CHN | 1 | 0.003 |
| HU-TUR | 258 | 0.828 |
| HU-USA | 382 | 0.989 |
| HU-VNM | 3 | 0.007 |
| IMU-MYS | 316 | 0.969 |
| ISCSEM-PRT | 221 | 0.695 |
| ISHIK Univ-IRQ | 221 | 0.695 |
| ISMMS-USA | 3 | 0.007 |
| IUMS-AUS | 258 | 0.828 |
| IUMS-IRN | 316 | 0.969 |
| IU-System-USA | 20 | 0.040 |
| JazanU-SAU | 316 | 0.969 |
| JCU-AUS | 278 | 0.850 |
| Jena Univ-DEU | 221 | 0.695 |
| JHU-USA | 374 | 0.984 |
| JKUAT-KEN | 9 | 0.019 |
| JLU-CHN | 41 | 0.059 |
| JLU-DEU | 3 | 0.004 |
| JMU-DEU | 1 | 0.000 |
| JMU-JPN | 4 | 0.000 |
| JNU-CHN | 50 | 0.076 |
| JSU-USA | 316 | 0.969 |
| JU-ETH | 320 | 0.970 |
| JU-POL | 316 | 0.969 |
| JU-SAU | 2 | 0.000 |
| JUST-JOR | 316 | 0.969 |
| KAU-SAU | 3 | 0.007 |
| KazNMU-KAZ | 221 | 0.695 |
| KBU-TUR | 258 | 0.828 |
| KGMU-IND | 258 | 0.828 |
| KHU-KOR | 221 | 0.695 |
| KI-SWE | 345 | 0.978 |
| KKU-THA | 54 | 0.090 |
| KLE Univ-IND | 40 | 0.056 |
| KMU-IRN | 258 | 0.828 |
| KNUST-GHA | 72 | 0.167 |
| KSAU-HS-SAU | 3 | 0.000 |
| KSU-SAU | 319 | 0.970 |
| KU Leuven-BEL | 20 | 0.031 |
| KU-KEN | 4 | 0.007 |
| KU-KOR | 316 | 0.969 |
| KUMS-IRN | 258 | 0.828 |
| KU-NPL | 36 | 0.065 |
| KU-SDN | 2 | 0.000 |
| KU-TUR | 22 | 0.046 |
| KU-USA | 221 | 0.695 |
| Kyoto U-JPN | 221 | 0.695 |
| LAMU-ZMB | 3 | 0.006 |
| LASU-NGA | 18 | 0.014 |
| LaTrobeU-AUS | 223 | 0.696 |
| LAUTECH-NGA | 2 | 0.000 |
| Lboro-GBR | 1 | 0.004 |
| LCWU-PAK | 258 | 0.828 |
| LEI-NLD | 6 | 0.017 |
| LIMU-LBY | 4 | 0.006 |
| LIU-JPN | 221 | 0.695 |
| Ljubliana UMC-SVN | 41 | 0.059 |
| LMU Munich-DEU | 287 | 0.843 |
| LSMU-LTU | 6 | 0.014 |
| LSU-system-USA | 25 | 0.052 |
| LUC-USA | 57 | 0.147 |
| LU-GBR | 3 | 0.006 |
| LU-SWE | 323 | 0.971 |
| MA-EGY | 320 | 0.970 |
| Mak-UGA | 292 | 0.852 |
| Marburg Univ-DEU | 2 | 0.000 |
| MazUMS-IRN | 221 | 0.695 |
| McGill-CAN | 292 | 0.840 |
| McMaster-CAN | 258 | 0.828 |
| MedUni Vienna-AUT | 13 | 0.022 |
| Minia-EGY | 1 | 0.000 |
| MLU-DEU | 221 | 0.695 |
| MMU-UGA | 1 | 0.003 |
| Mohammed V-MAR | 3 | 0.004 |
| MQ-AUS | 4 | 0.008 |
| MSM-USA | 3 | 0.004 |
| MSU-KEN | 5 | 0.012 |
| MSUMD-RUS | 57 | 0.147 |
| MSU-USA | 58 | 0.147 |
| MTU-ETH | 221 | 0.695 |
| MU-ETH | 321 | 0.970 |
| MUHAS-TZA | 343 | 0.976 |
| MUHS-IND | 33 | 0.059 |
| MU-KEN | 54 | 0.093 |
| MUK-IRN | 342 | 0.977 |
| MUL-POL | 41 | 0.059 |
| MUMS-IRN | 221 | 0.695 |
| MUST-EGY | 4 | 0.000 |
| MUST-MWI | 6 | 0.011 |
| MUST-UGA | 3 | 0.004 |
| MWU-ETH | 226 | 0.699 |
| NCU-JPN | 3 | 0.004 |
| NEU-USA | 316 | 0.969 |
| Newcastle Univ-GBR | 258 | 0.828 |
| NIAID-USA | 2 | 0.000 |
| NJU-CHN | 316 | 0.969 |
| NMCBGK-IND | 10 | 0.014 |
| NMU-JPN | 41 | 0.059 |
| NTU-SGP | 221 | 0.695 |
| NU-GBR | 317 | 0.970 |
| NUIG-IRL | 57 | 0.147 |
| NUS-SGP | 357 | 0.986 |
| NU-System-USA | 1 | 0.001 |
| NU-USA | 341 | 0.981 |
| NWU-ZAF | 316 | 0.969 |
| NYU-USA | 262 | 0.829 |
| OAU-NGA | 66 | 0.084 |
| OHSU-USA | 260 | 0.829 |
| OOU-NGA | 3 | 0.003 |
| OSU-System-USA | 265 | 0.830 |
| OUCRU-VNM | 258 | 0.828 |
| OUHS-IND | 16 | 0.012 |
| OX-GBR | 380 | 0.990 |
| Paris V-FRA | 30 | 0.050 |
| Paris XI-FRA | 2 | 0.000 |
| PHSU-USA | 258 | 0.828 |
| Pitt-USA | 316 | 0.969 |
| PKU-CHN | 13 | 0.031 |
| PolyU-CHN | 221 | 0.695 |
| PSU-USA | 9 | 0.017 |
| PU-IND | 1 | 0.000 |
| PUJ-COL | 317 | 0.970 |
| PU-KEN | 6 | 0.016 |
| Purdue-System-USA | 7 | 0.015 |
| PU-USA | 2 | 0.007 |
| Qom MS-IRN | 258 | 0.828 |
| QU-CAN | 2 | 0.003 |
| QUMS-IRN | 221 | 0.695 |
| QU-SAU | 1 | 0.000 |
| QUT-AUS | 316 | 0.969 |
| Rennes-FRA | 4 | 0.004 |
| RGU-IND | 16 | 0.012 |
| RUDN-RUS | 41 | 0.059 |
| RUG-NLD | 322 | 0.970 |
| RU-ISL | 316 | 0.969 |
| RU-NLD | 5 | 0.010 |
| RUSM-USA | 1 | 0.004 |
| RU-System-USA | 17 | 0.049 |
| RU-USA | 9 | 0.017 |
| Sapienza-ITA | 342 | 0.977 |
| SAUT-TZA | 1 | 0.003 |
| SBUMS-IRN | 316 | 0.969 |
| SCU-EGY | 259 | 0.828 |
| SDU-CHN | 41 | 0.059 |
| SDU-DNK | 38 | 0.069 |
| SFU-CAN | 258 | 0.828 |
| SJSM-GBR | 258 | 0.828 |
| SJTU-CHN | 273 | 0.747 |
| SJU-USA | 4 | 0.000 |
| SKKU-KOR | 258 | 0.828 |
| SLC-CAN | 2 | 0.003 |
| SLU-USA | 36 | 0.065 |
| SMU-BGD | 16 | 0.012 |
| SMU-JPN | 7 | 0.014 |
| SNU-KOR | 316 | 0.969 |
| Southern UC-MYS | 258 | 0.828 |
| SPHMMC-ETH | 19 | 0.050 |
| SRU-IND | 316 | 0.969 |
| St Andrews-GBR | 7 | 0.018 |
| StOlaf-USA | 2 | 0.003 |
| SUE-IRQ | 316 | 0.969 |
| SU-ETH | 222 | 0.695 |
| SUNY-USA | 261 | 0.829 |
| SUSF -USA | 321 | 0.970 |
| SUST-BGD | 16 | 0.012 |
| SU-SWE | 259 | 0.828 |
| SU-USA | 266 | 0.832 |
| SU-ZAF | 356 | 0.979 |
| SUZA-TZA | 3 | 0.004 |
| SYSU-CHN | 321 | 0.970 |
| SZU-CHN | 9 | 0.017 |
| TaibahU-SAU | 1 | 0.003 |
| TAU-FIN | 327 | 0.973 |
| TCNJ-USA | 5 | 0.014 |
| TJU-USA | 12 | 0.029 |
| TNMGRMU-IND | 325 | 0.972 |
| Tor Vergata-ITA | 19 | 0.029 |
| Touro-System-USA | 258 | 0.828 |
| TSMU-GEO | 41 | 0.059 |
| TSU-CHN | 3 | 0.002 |
| TTU-System-USA | 3 | 0.010 |
| TU-EGY | 4 | 0.003 |
| TUMa-TZA | 8 | 0.014 |
| TUMS-IRN | 316 | 0.969 |
| TU-NPL | 7 | 0.013 |
| TUOS-GBR | 317 | 0.970 |
| TU-SAU | 3 | 0.000 |
| TU-SVK | 316 | 0.969 |
| TU-USA | 24 | 0.047 |
| UAB-LBN | 8 | 0.023 |
| UAb-PRT | 316 | 0.969 |
| UAC-BEN | 15 | 0.018 |
| UAEU-ARE | 224 | 0.696 |
| UAlberta-CAN | 282 | 0.838 |
| UAM-ESP | 316 | 0.969 |
| UAM-MEX | 227 | 0.700 |
| UANDES-CHL | 18 | 0.048 |
| UAntwerp-BEL | 46 | 0.068 |
| UA-System-USA | 362 | 0.986 |
| Uautonoma-CHL | 258 | 0.828 |
| UBath-GBR | 258 | 0.828 |
| UB-BWA | 5 | 0.012 |
| UBC-CAN | 337 | 0.979 |
| UB-CHE | 362 | 0.982 |
| UB-ESP | 327 | 0.971 |
| UB-FRA | 221 | 0.695 |
| UB-GBR | 9 | 0.018 |
| UB-LBY | 4 | 0.006 |
| UBordeaux-FRA | 6 | 0.017 |
| UBrandeis-USA | 258 | 0.828 |
| UBrown-USA | 285 | 0.852 |
| UB-SRB | 316 | 0.969 |
| UB-USA | 24 | 0.046 |
| UC Chile-CHL | 255 | 0.714 |
| UCalgary-CAN | 338 | 0.976 |
| UCAR-TUN | 4 | 0.004 |
| UC-AUS | 316 | 0.969 |
| UCC-GHA | 321 | 0.971 |
| UCC-IRL | 316 | 0.969 |
| UCG-ZAR | 1 | 0.001 |
| UChicago-USA | 61 | 0.159 |
| UCLan-GBR | 5 | 0.013 |
| UCM-ESP | 12 | 0.021 |
| UC-NZL | 258 | 0.828 |
| UColgate-USA | 258 | 0.828 |
| UCPEL-BRA | 31 | 0.075 |
| UCPH-DNK | 340 | 0.975 |
| UCP-PRT | 221 | 0.695 |
| UCR-CRI | 316 | 0.969 |
| UC-System-USA | 380 | 0.988 |
| UCT-ZAF | 337 | 0.980 |
| UC-USA | 263 | 0.828 |
| UCU-UGA | 3 | 0.007 |
| UDCA-COL | 258 | 0.828 |
| Udelar-URY | 258 | 0.828 |
| UdeM-CAN | 330 | 0.972 |
| UDESC-BRA | 258 | 0.828 |
| UD-GBR | 4 | 0.000 |
| UDla-CMR | 1 | 0.000 |
| UDOM-TZA | 3 | 0.004 |
| UDP-CHL | 4 | 0.010 |
| UDS-GHA | 5 | 0.007 |
| UDSM-TZA | 2 | 0.000 |
| UD-USA | 62 | 0.161 |
| UDUS-NGA | 2 | 0.000 |
| UEA-GBR | 221 | 0.695 |
| UEF-FIN | 3 | 0.004 |
| UEM-MOZ | 66 | 0.165 |
| UERMMMC-PHL | 258 | 0.828 |
| UEX-ESP | 258 | 0.828 |
| UFAS-DZA | 221 | 0.695 |
| UFBA-BRA | 20 | 0.049 |
| UFC-BRA | 7 | 0.013 |
| UFHB-CIV | 6 | 0.011 |
| UFH-ZAF | 1 | 0.000 |
| UFMG-BRA | 319 | 0.970 |
| UFM-GTM | 10 | 0.014 |
| UFPel-BRA | 70 | 0.143 |
| UFRGS-BRA | 316 | 0.969 |
| UFS-BRA | 316 | 0.969 |
| UFSC-BRA | 316 | 0.969 |
| UGent-BEL | 357 | 0.981 |
| UG-GHA | 60 | 0.121 |
| UG-System-USA | 40 | 0.076 |
| UHAS-GHA | 7 | 0.012 |
| Uhasselt-BEL | 18 | 0.029 |
| UH-FIN | 342 | 0.977 |
| UHoward-USA | 333 | 0.979 |
| UHS Lahore | 16 | 0.012 |
| UHS Lahore-PAK | 221 | 0.695 |
| UH-System-USA | 4 | 0.007 |
| UiB-NOR | 349 | 0.979 |
| UIC-ESP | 3 | 0.004 |
| UIdaho-USA | 9 | 0.018 |
| UI-IDN | 20 | 0.052 |
| UImperial-GBR | 360 | 0.985 |
| UI-NGA | 273 | 0.836 |
| UiO-NOR | 321 | 0.970 |
| UIowa-USA | 259 | 0.828 |
| UiS-NOR | 4 | 0.010 |
| UI-System-USA | 258 | 0.828 |
| UiTM-MYS | 2 | 0.000 |
| UiT-NOR | 316 | 0.969 |
| UJLG-CIV | 3 | 0.004 |
| UKCS-SRB | 41 | 0.059 |
| UKF-SVK | 3 | 0.003 |
| UK-KOR | 316 | 0.969 |
| UKM-MYS | 327 | 0.972 |
| UK-SRB | 316 | 0.969 |
| UKY-USA | 6 | 0.014 |
| UKZN-ZAF | 324 | 0.972 |
| ULancaster-GBR | 221 | 0.695 |
| ULB-BEL | 1 | 0.000 |
| ULeeds-GBR | 5 | 0.017 |
| UL-FRA | 316 | 0.969 |
| UL-GBR | 258 | 0.828 |
| ULisboa-PRT | 221 | 0.695 |
| UL-LVA | 41 | 0.059 |
| Ulm-DEU | 316 | 0.969 |
| UL-TGO | 258 | 0.828 |
| UManitoba-CAN | 316 | 0.969 |
| UMass-System-USA | 318 | 0.970 |
| UM-AUS | 253 | 0.741 |
| UMDNJ-USA | 17 | 0.029 |
| UM-EGY | 3 | 0.000 |
| UMFCD-ROM | 316 | 0.969 |
| UMGA-MDG | 1 | 0.000 |
| UM-GBR | 41 | 0.076 |
| UMG-USA | 15 | 0.025 |
| UMiami-USA | 57 | 0.147 |
| UMich-System-USA | 30 | 0.064 |
| UMIT TIROL-AUT | 258 | 0.828 |
| UM-MYS | 6 | 0.007 |
| UM-NLD | 5 | 0.007 |
| UMontpellier-FRA | 4 | 0.004 |
| UMSHA-IRN | 221 | 0.695 |
| UM-System-USA | 278 | 0.850 |
| UMT-ALB | 41 | 0.059 |
| UM-THA | 32 | 0.079 |
| UMT-PAK | 316 | 0.969 |
| UM-TUN | 5 | 0.004 |
| UM-TUR | 20 | 0.049 |
| UM-USA | 316 | 0.969 |
| UMU-SWE | 3 | 0.010 |
| UNAL-COL | 316 | 0.969 |
| UNB-BFA | 1 | 0.000 |
| UnB-BRA | 258 | 0.828 |
| UNC-System-USA | 367 | 0.984 |
| Uni Bielefeld-DEU | 316 | 0.969 |
| Uni Freiburg-DEU | 44 | 0.060 |
| Uni Heidelberg-DEU | 319 | 0.970 |
| Uni Hohenheim-DEU | 318 | 0.970 |
| Uni Tubingen-DEU | 43 | 0.073 |
| UNIABUJA-NGA | 17 | 0.014 |
| UniBa-ITA | 316 | 0.969 |
| UNIBEN-NGA | 21 | 0.023 |
| UNIBO-ITA | 316 | 0.969 |
| UNICA-ITA | 18 | 0.029 |
| UNICAL-NGA | 4 | 0.004 |
| UNICAMP-BRA | 36 | 0.065 |
| UNICARTAGENA-COL | 316 | 0.969 |
| UNIFESP-BRA | 49 | 0.086 |
| UNIFI-ITA | 31 | 0.067 |
| UNIFR-CHE | 2 | 0.000 |
| UNIGE-CHE | 3 | 0.003 |
| UNIJOS-NGA | 12 | 0.017 |
| UNIKIN-ZAR | 254 | 0.721 |
| UNILAG-NGA | 228 | 0.702 |
| UNIL-CHE | 18 | 0.029 |
| UNILIM-FRA | 2 | 0.000 |
| UNILORIN-NGA | 20 | 0.015 |
| UNILU-ZAR | 3 | 0.003 |
| UNIMAID-NGA | 4 | 0.004 |
| UNIMA-MWI | 85 | 0.161 |
| UNIMED-NGA | 2 | 0.000 |
| UniME-ITA | 18 | 0.029 |
| UNIMELB-AUS | 339 | 0.980 |
| UNIMI-ITA | 353 | 0.979 |
| UniofExter-GBR | 2 | 0.004 |
| UniOulu -FIN | 3 | 0.007 |
| UniPD-ITA | 3 | 0.010 |
| UNIPG-ITA | 41 | 0.059 |
| UNIPORT-NGA | 4 | 0.004 |
| UNIPR-ITA | 18 | 0.029 |
| UNIPV-ITA | 22 | 0.046 |
| UniSA-AUS | 261 | 0.831 |
| UNISA-ITA | 316 | 0.969 |
| UNISA-ZAF | 57 | 0.147 |
| UNIST-HRV | 6 | 0.014 |
| UNISTRA-FRA | 2 | 0.000 |
| UNISUL-BRA | 258 | 0.828 |
| UniTo-ITA | 30 | 0.056 |
| UniTS-ITA | 1 | 0.003 |
| UNIVEN-ZAF | 7 | 0.013 |
| UNIZIK-NGA | 3 | 0.004 |
| UNM-USA | 323 | 0.971 |
| UNNES-IDN | 221 | 0.695 |
| UNN-NGA | 225 | 0.702 |
| UNSW-AUS | 333 | 0.978 |
| UNZA-ZMB | 325 | 0.971 |
| UoA-NZL | 338 | 0.980 |
| UO-BFA | 1 | 0.003 |
| UOB-LBN | 2 | 0.004 |
| UoC-DEU | 1 | 0.000 |
| UoC-LKA | 258 | 0.828 |
| UOEH-JPN | 316 | 0.969 |
| UofA-System-USA | 3 | 0.003 |
| UofA-USA | 318 | 0.970 |
| UofG-CAN | 2 | 0.006 |
| UofG-SDN | 22 | 0.046 |
| UofK-SDN | 37 | 0.065 |
| UofL-USA | 266 | 0.832 |
| UofM-System-USA | 14 | 0.019 |
| UoG-ETH | 319 | 0.970 |
| UOH-SAU | 221 | 0.695 |
| UoL-GBR | 433 | 1.000 |
| UoN-KEN | 335 | 0.972 |
| UO-NZL | 278 | 0.850 |
| UO-System-USA | 336 | 0.974 |
| UOT-LBY | 22 | 0.046 |
| uOttawa-CAN | 317 | 0.969 |
| UOW-AUS | 1 | 0.003 |
| UPenn-USA | 285 | 0.853 |
| UPeradeniya-LKA | 278 | 0.850 |
| UPF-ESP | 258 | 0.828 |
| UPMC-FRA | 6 | 0.004 |
| UPMC-USA | 5 | 0.014 |
| UPM-PHL | 221 | 0.695 |
| UPNG -PNG | 316 | 0.969 |
| UP-PHL | 258 | 0.828 |
| UP-PRT | 320 | 0.971 |
| UP-ZAF | 37 | 0.072 |
| UQ-AUS | 337 | 0.980 |
| UQU-SAU | 2 | 0.000 |
| URC-USA | 36 | 0.065 |
| URI-USA | 260 | 0.829 |
| URochester-USA | 4 | 0.007 |
| UR-RWA | 8 | 0.012 |
| UR-USA | 36 | 0.065 |
| URV-ESP | 18 | 0.029 |
| USAC-GTM | 12 | 0.023 |
| uSask -CAN | 221 | 0.695 |
| USA-USA | 15 | 0.025 |
| USC-PHL | 24 | 0.062 |
| USC-System-USA | 7 | 0.017 |
| US-GBR | 348 | 0.979 |
| USG-USA | 3 | 0.007 |
| USL-SLE | 22 | 0.046 |
| USM-MYS | 316 | 0.969 |
| USM-System-USA | 32 | 0.069 |
| USO-TUN | 4 | 0.004 |
| USP-BRA | 352 | 0.979 |
| USS-GAB | 7 | 0.004 |
| US-USA | 221 | 0.695 |
| USYD-AUS | 331 | 0.978 |
| UTAS-AUS | 258 | 0.828 |
| UTennessee-System-USA | 344 | 0.978 |
| UT-EST | 221 | 0.695 |
| UTH-GRC | 248 | 0.706 |
| UTM-TUN | 7 | 0.007 |
| Utokyo-JPN | 246 | 0.734 |
| UToronto-CAN | 352 | 0.979 |
| UTS-AUS | 37 | 0.065 |
| UT-System-USA | 248 | 0.737 |
| UT-USA | 319 | 0.970 |
| UU-IND | 221 | 0.695 |
| UU-NLD | 44 | 0.080 |
| UU-SWE | 323 | 0.972 |
| UU-USA | 258 | 0.828 |
| UvA-NLD | 10 | 0.011 |
| UVA-USA | 333 | 0.972 |
| UV-ESP | 316 | 0.969 |
| UVSQ-FRA | 3 | 0.000 |
| UW System-USA | 2 | 0.003 |
| UWA-AUS | 344 | 0.981 |
| UWC-ZAF | 3 | 0.006 |
| UWE-GBR | 258 | 0.828 |
| UW-GBR | 317 | 0.970 |
| UWI-JAM | 7 | 0.015 |
| UWK-AUT | 258 | 0.828 |
| UW-KEN | 3 | 0.010 |
| UWO-CAN | 258 | 0.828 |
| UWS-AUS | 316 | 0.969 |
| UW-USA | 384 | 0.990 |
| UYI-CMR | 4 | 0.007 |
| UZ Brussel-BEL | 41 | 0.059 |
| UZH-CHE | 269 | 0.830 |
| UZ-ZWE | 33 | 0.079 |
| Vandy-USA | 62 | 0.157 |
| VCU-USA | 316 | 0.969 |
| Virginia Tech-USA | 258 | 0.828 |
| VU Amsterdam-NLD | 25 | 0.049 |
| VU-CAN | 4 | 0.006 |
| VU-LTU | 41 | 0.059 |
| WAIT-AUS | 316 | 0.969 |
| WaldenU-USA | 261 | 0.829 |
| WCM-Q-QAT | 258 | 0.828 |
| WCRI-CAN | 6 | 0.017 |
| WFU-USA | 58 | 0.151 |
| Wits Univ-ZAF | 375 | 0.988 |
| WKU-USA | 6 | 0.014 |
| WMU-CHN | 41 | 0.059 |
| WMU-POL | 316 | 0.969 |
| WSU-ETH | 15 | 0.040 |
| WSU-System -USA | 9 | 0.018 |
| WSU-USA | 261 | 0.828 |
| WU-ETH | 221 | 0.695 |
| WUR-NLD | 316 | 0.969 |
| WUSTL-USA | 221 | 0.695 |
| WVU System-USA | 2 | 0.003 |
| XJTU-CHN | 23 | 0.059 |
| XMU-MYS | 221 | 0.695 |
| YCU-JPN | 221 | 0.695 |
| York Univ-CAN | 3 | 0.003 |
| York Univ-GBR | 260 | 0.829 |
| YU-KOR | 316 | 0.969 |
| YU-USA | 351 | 0.984 |
| ZJU-CHN | 62 | 0.101 |
| ZU-ARE | 2 | 0.000 |
| ZU-EGY | 4 | 0.000 |
| ZUMS-IRN | 221 | 0.695 |
Table 12.
Impact of the articles according to the type of collaboration and period of publication. Note: for several periods, the number of articles is below 20 (see Table 5 above).
Table 12.
Impact of the articles according to the type of collaboration and period of publication. Note: for several periods, the number of articles is below 20 (see Table 5 above).
| Period | CNCI (median) | ||
|---|---|---|---|
| DRC | IRC | no_coll | |
| 2000–2019 | 0.504 | 1.083 | 0.300 |
| 2000–2004 | 0.467 | 0.673 | 0.299 |
| 2005–2009 | 0.468 | 1.061 | 0.000 |
| 2010–2014 | 0.514 | 1.272 | 0.349 |
| 2015–2019 | 0.500 | 1.038 | 0.206 |
Table 13.
Impact of the articles according to the different types of IRC and period of publication. Note: for several periods, the number of articles is below 20.
Table 13.
Impact of the articles according to the different types of IRC and period of publication. Note: for several periods, the number of articles is below 20.
| Period | CNCI (median) | ||
|---|---|---|---|
| IRCintra | IRCinter | IRCinter_intra | |
| 2000–2019 | 0.724 | 1.012 | 1.369 |
| 2000–2004 | 0.000 | 0.673 | 1.371 |
| 2005–2009 | 0.264 | 1.009 | 1.624 |
| 2010–2014 | 0.479 | 1.225 | 1.913 |
| 2015–2019 | 0.783 | 0.981 | 1.265 |
Table 14.
The number of articles with research collaboration by topic and period.
| Micro-Topic | Pub (nº) | ||||
|---|---|---|---|---|---|
| 2000–2019 | 2000–2004 | 2005–2009 | 2010–2014 | 2015–2019 | |
| 1.156.381 Maternal Mortality | 191 | 6 | 21 | 57 | 107 |
| 1.23.1757 Group B Streptococcus | 125 | 8 | 9 | 28 | 80 |
| 1.117.1389 Bilirubin | 91 | 1 | 8 | 24 | 58 |
| 1.72.182 Gestational Diabetes Mellitus | 88 | 3 | 7 | 24 | 54 |
| 1.72.924 Preterm Labor | 64 | 2 | 6 | 11 | 45 |
| 1.72.531 Preeclampsia | 58 | 3 | 9 | 10 | 36 |
| 1.66.11 HIV Prevalence & Prophylaxis | 49 | 1 | 5 | 12 | 31 |
| 1.217.59 Malaria | 39 | 1 | 6 | 15 | 17 |
| 1.72.922 Fetal Heart Rate | 37 | 0 | 9 | 6 | 22 |
| 1.72.1732 Patent Ductus Arteriosus | 25 | 3 | 1 | 9 | 12 |
| 1.72.748 Preterm Infants | 23 | 0 | 1 | 9 | 13 |
| 1.23.146 Antibiotic Resistance | 21 | 0 | 1 | 3 | 17 |
| 1.44.1198 Food Insecurity | 19 | 0 | 0 | 9 | 10 |
| 1.216.2287 Gastroschisis | 18 | 1 | 2 | 1 | 14 |
| 1.72.808 Breech Presentation | 17 | 1 | 1 | 1 | 14 |
| 1.184.573 Iron Overload | 13 | 1 | 1 | 4 | 7 |
| 1.248.655 Chlamydia Trachomatis | 13 | 0 | 2 | 1 | 10 |
| 1.72.891 Breastfeeding | 12 | 1 | 2 | 2 | 7 |
| 1.125.1718 Hepatitis E Virus | 11 | 2 | 3 | 1 | 5 |
| 1.72.1072 Postpartum Depression | 11 | 0 | 1 | 1 | 9 |
| 1.80.279 Vitamin D | 11 | 0 | 1 | 0 | 10 |
| 1.225.2074 Methemoglobinemia | 10 | 0 | 0 | 6 | 4 |
| 1.49.468 Oral Health | 10 | 0 | 0 | 2 | 8 |
| 1.154.1057 Pulmonary Surfactant | 8 | 0 | 2 | 2 | 4 |
| 1.156.2047 Global Surgery | 8 | 0 | 1 | 2 | 5 |
| 1.157.728 Biliary Atresia | 8 | 1 | 1 | 1 | 5 |
| 1.75.326 Antiphospholipid Syndrome | 8 | 0 | 1 | 4 | 3 |
| 1.81.979 Twin-Twin Transfusion Syndrome | 7 | 0 | 1 | 3 | 3 |
| 8.124.552 Air Pollution | 7 | 0 | 0 | 1 | 6 |
| 1.150.1148 Deaf | 6 | 0 | 3 | 0 | 3 |
| 1.55.830 Acute Kidney Injury | 6 | 0 | 2 | 0 | 4 |
| 1.120.384 Gut Microbiota | 5 | 0 | 0 | 2 | 3 |
| 1.148.94 Candida Albicans | 5 | 0 | 0 | 2 | 3 |
| 1.151.222 Laparoscopic Cholecystectomy | 5 | 0 | 0 | 0 | 5 |
| 1.225.626 Sickle Cell Disease | 5 | 0 | 0 | 1 | 4 |
| 1.103.1225 ITP | 4 | 0 | 1 | 3 | 0 |
| 1.104.975 Respiratory Syncytial Virus | 4 | 1 | 0 | 1 | 2 |
| 1.137.217 Melatonin | 4 | 0 | 0 | 0 | 4 |
| 1.154.360 Procalcitonin | 4 | 0 | 0 | 1 | 3 |
| 1.23.173 Staphylococcus Aureus | 4 | 0 | 0 | 0 | 4 |
| 1.42.678 Listeria Monocytogenes | 4 | 1 | 1 | 0 | 2 |
| 1.82.1066 Cerebral Palsy | 4 | 0 | 0 | 3 | 1 |
| 1.104.126 Influenza | 3 | 0 | 0 | 1 | 2 |
| 1.125.275 HBV | 3 | 0 | 0 | 0 | 3 |
| 1.128.482 Contraception | 3 | 0 | 0 | 0 | 3 |
| 1.161.711 Cytomegalovirus | 3 | 0 | 1 | 1 | 1 |
| 1.194.273 Mycobacterium Tuberculosis & Leprosy | 3 | 0 | 0 | 1 | 2 |
| 1.216.1563 Volvulus | 3 | 0 | 0 | 0 | 3 |
| 1.216.1996 Pneumomediastinum | 3 | 0 | 0 | 1 | 2 |
| 1.231.432 Homocysteine | 3 | 1 | 0 | 1 | 1 |
| 1.248.1317 Mycoplasma | 3 | 0 | 0 | 2 | 1 |
| 1.248.2104 Trichomonas Vaginalis | 3 | 1 | 0 | 1 | 1 |
| 1.257.983 Hydrocephalus | 3 | 0 | 0 | 2 | 1 |
| 1.37.309 Congenital Heart Disease | 3 | 0 | 0 | 1 | 2 |
| 1.72.1745 Hyperemesis Gravidarum | 3 | 0 | 0 | 2 | 1 |
| 1.95.723 Irritable Bowel Syndrome | 3 | 0 | 2 | 1 | 0 |
| 3.91.920 Selenium | 3 | 0 | 1 | 0 | 2 |
| 6.24.858 Intimate Partner Violence | 3 | 0 | 0 | 1 | 2 |
| 1.125.83 HCV | 2 | 1 | 1 | 0 | 0 |
| 1.141.407 Acute Promyelocytic Leukemia | 2 | 1 | 0 | 0 | 1 |
| 1.161.315 HSV-1 | 2 | 0 | 0 | 2 | 0 |
| 1.222.143 Epilepsy | 2 | 0 | 1 | 1 | 0 |
| 1.228.994 Ebola Virus | 2 | 0 | 0 | 0 | 2 |
| 1.23.1036 Surgical Site Infection | 2 | 1 | 0 | 0 | 1 |
| 1.23.422 Gentamicin | 2 | 0 | 0 | 1 | 1 |
| 1.235.1679 Foreign Body | 2 | 0 | 0 | 0 | 2 |
| 1.258.1958 Leptospirosis | 2 | 0 | 0 | 0 | 2 |
| 1.286.845 Complement | 2 | 0 | 1 | 0 | 1 |
| 1.42.545 STEC | 2 | 0 | 0 | 0 | 2 |
| 1.6.351 Endotoxin | 2 | 0 | 0 | 1 | 1 |
| 1.81.1272 HLA-G | 2 | 0 | 0 | 0 | 2 |
| 1.81.1408 Fertility Preservation | 2 | 0 | 0 | 1 | 1 |
| 4.61.1124 Rough Sets | 2 | 0 | 0 | 1 | 1 |
| 6.178.516 Divorce | 2 | 0 | 0 | 0 | 2 |
| 1.100.1284 Fetal Alcohol Syndrome | 1 | 0 | 0 | 0 | 1 |
| 1.104.1770 Pertussis | 1 | 0 | 0 | 0 | 1 |
| 1.104.901 Foot-And-Mouth Disease Virus | 1 | 0 | 0 | 0 | 1 |
| 1.105.1677 Vertebral Artery Dissection | 1 | 0 | 0 | 1 | 0 |
| 1.111.162 Hepatocellular Carcinoma | 1 | 1 | 0 | 0 | 0 |
| 1.117.1309 Acetaminophen | 1 | 0 | 0 | 1 | 0 |
| 1.127.1303 Endothelin | 1 | 0 | 0 | 1 | 0 |
| 1.128.1489 Hysteroscopy | 1 | 0 | 0 | 0 | 1 |
| 1.128.1521 Ectopic Pregnancy | 1 | 0 | 0 | 0 | 1 |
| 1.132.2267 Clubfoot | 1 | 0 | 0 | 0 | 1 |
| 1.132.759 Matrix Metalloproteinases | 1 | 0 | 1 | 0 | 0 |
| 1.136.1749 Down Syndrome | 1 | 0 | 0 | 0 | 1 |
| 1.136.1780 Family Quality Of Life | 1 | 0 | 0 | 0 | 1 |
| 1.136.283 Autism | 1 | 0 | 0 | 0 | 1 |
| 1.14.1293 Emergency Department | 1 | 0 | 0 | 0 | 1 |
| 1.14.1359 Interprofessional Education | 1 | 0 | 0 | 0 | 1 |
| 1.142.1628 Urinary Diversion | 1 | 1 | 0 | 0 | 0 |
| 1.142.832 Fecal Incontinence | 1 | 0 | 0 | 0 | 1 |
| 1.154.1088 Intensive Care | 1 | 0 | 0 | 0 | 1 |
| 1.154.277 Mechanical Ventilation | 1 | 0 | 0 | 0 | 1 |
| 1.155.598 Informed Consent | 1 | 0 | 0 | 0 | 1 |
| 1.158.2138 Porokeratosis | 1 | 0 | 0 | 0 | 1 |
| 1.163.446 Schistosomiasis | 1 | 0 | 0 | 0 | 1 |
| 1.164.1871 Menarche | 1 | 0 | 0 | 0 | 1 |
| 1.168.671 Vascular Access | 1 | 0 | 0 | 1 | 0 |
| 1.179.108 Human Papillomavirus | 1 | 0 | 0 | 0 | 1 |
| 1.184.1030 Erythropoietin | 1 | 1 | 0 | 0 | 0 |
| 1.184.653 Zinc | 1 | 0 | 0 | 0 | 1 |
| 1.186.1008 Nuchal Translucency | 1 | 0 | 0 | 0 | 1 |
| 1.186.948 Digeorge Syndrome | 1 | 0 | 0 | 0 | 1 |
| 1.195.1341 Enteric Nervous System | 1 | 1 | 0 | 0 | 0 |
| 1.199.1048 Pleurodesis | 1 | 1 | 0 | 0 | 0 |
| 1.213.168 Hypothyroidism | 1 | 0 | 0 | 1 | 0 |
| 1.216.2098 Intussusception | 1 | 0 | 1 | 0 | 0 |
| 1.217.1038 Toxoplasma Gondii | 1 | 0 | 0 | 1 | 0 |
| 1.225.1476 Alloimmunization | 1 | 0 | 0 | 0 | 1 |
| 1.225.786 Spectrin | 1 | 0 | 0 | 0 | 1 |
| 1.228.200 Dengue | 1 | 0 | 0 | 0 | 1 |
| 1.23.1397 Urinary Tract Infection | 1 | 0 | 0 | 0 | 1 |
| 1.23.714 Neisseria Meningitidis | 1 | 0 | 0 | 0 | 1 |
| 1.235.1617 Deglutition | 1 | 0 | 0 | 0 | 1 |
| 1.236.1155 Capsule Endoscopy | 1 | 0 | 0 | 1 | 0 |
| 1.236.312 Portal Hypertension | 1 | 0 | 0 | 0 | 1 |
| 1.243.1012 Vesicoureteral Reflux | 1 | 0 | 0 | 1 | 0 |
| 1.246.710 Rotavirus | 1 | 1 | 0 | 0 | 0 |
| 1.258.227 Lyme Disease | 1 | 0 | 0 | 1 | 0 |
| 1.26.107 Adiponectin | 1 | 0 | 0 | 0 | 1 |
| 1.26.337 Leptin | 1 | 0 | 1 | 0 | 0 |
| 1.261.596 Trypanosoma Cruzi | 1 | 0 | 1 | 0 | 0 |
| 1.266.1068 Pressure Ulcer | 1 | 0 | 0 | 0 | 1 |
| 1.278.1796 Neuroblastoma | 1 | 0 | 0 | 1 | 0 |
| 1.281.1236 Amyloidosis | 1 | 0 | 0 | 1 | 0 |
| 1.324.2020 Tetanus | 1 | 0 | 1 | 0 | 0 |
| 1.34.1657 Elbow | 1 | 0 | 0 | 1 | 0 |
| 1.36.2059 Retinopathy Of Prematurity | 1 | 0 | 0 | 0 | 1 |
| 1.37.467 Echocardiography | 1 | 0 | 0 | 1 | 0 |
| 1.49.1061 Endodontics | 1 | 0 | 0 | 0 | 1 |
| 1.5.1674 Ketogenic Diet | 1 | 0 | 1 | 0 | 0 |
| 1.5.420 Cortisol | 1 | 0 | 0 | 0 | 1 |
| 1.54.1401 Genome Editing | 1 | 0 | 0 | 1 | 0 |
| 1.54.958 HMGB1 | 1 | 0 | 1 | 0 | 0 |
| 1.55.1904 ACE Gene | 1 | 0 | 0 | 0 | 1 |
| 1.6.452 Somatic Hypermutation | 1 | 0 | 0 | 0 | 1 |
| 1.6.609 Toll-like Receptors | 1 | 0 | 0 | 0 | 1 |
| 1.65.192 COPD | 1 | 0 | 0 | 1 | 0 |
| 1.66.1615 Aids Dementia Complex | 1 | 0 | 0 | 0 | 1 |
| 1.68.256 Docosahexaenoic Acid | 1 | 0 | 0 | 0 | 1 |
| 1.68.707 Alpha-Tocopherol | 1 | 0 | 1 | 0 | 0 |
| 1.71.2048 Mean Platelet Volume | 1 | 0 | 0 | 0 | 1 |
| 1.72.1710 Postpartum Hemorrhage | 1 | 0 | 0 | 0 | 1 |
| 1.82.1298 Spinal Cord Injury Rehabilitation | 1 | 0 | 0 | 0 | 1 |
| 1.94.1664 VKORC1 | 1 | 1 | 0 | 0 | 0 |
| 1.95.387 Helicobacter Pylori | 1 | 0 | 0 | 0 | 1 |
| 1.95.801 Cimetidine | 1 | 0 | 0 | 1 | 0 |
| 3.16.1496 Ethnobotany | 1 | 0 | 0 | 0 | 1 |
| 3.171.1011 Carotenoids | 1 | 0 | 0 | 0 | 1 |
| 3.180.2418 Alginate Lyase | 1 | 0 | 0 | 0 | 1 |
| 3.198.400 Mycotoxins | 1 | 0 | 0 | 1 | 0 |
| 3.91.496 Cadmium | 1 | 0 | 0 | 0 | 1 |
| 6.146.734 Anthropology | 1 | 0 | 0 | 0 | 1 |
| 6.73.2331 Health Locus of Control | 1 | 0 | 0 | 0 | 1 |
| 8.124.1648 Heat Waves | 1 | 0 | 0 | 0 | 1 |
Table 15.
The number of articles by topic and type of collaboration for the whole period.
| Micro-Topic | Collaboration | Pub (nº) | Micro-Topic | Collaboration | Pub (nº) | ||
|---|---|---|---|---|---|---|---|
| 1.100.1284 Fetal Alcohol Syndrome | DRC | 1 | 1.231.1650 Thiamine | no_coll | 1 | ||
| 1.103.1225 ITP | DRC | 2 | 1.231.432 Homocysteine | DRC | 1 | ||
| 1.103.1225 ITP | IRC | 2 | 1.231.432 Homocysteine | IRC | 2 | ||
| 1.104.126 Influenza | DRC | 1 | 1.235.1617 Deglutition | DRC | 1 | ||
| 1.104.126 Influenza | IRC | 2 | 1.235.1679 Foreign Body | IRC | 2 | ||
| 1.104.1770 Pertussis | IRC | 1 | 1.236.1155 Capsule Endoscopy | DRC | 1 | ||
| 1.104.901 Foot-And-Mouth Disease Virus | IRC | 1 | 1.236.312 Portal Hypertension | DRC | 1 | ||
| 1.104.975 Respiratory Syncytial Virus | DRC | 1 | 1.243.1012 Vesicoureteral Reflux | DRC | 1 | ||
| 1.104.975 Respiratory Syncytial Virus | IRC | 3 | 1.246.710 Rotavirus | DRC | 1 | ||
| 1.105.1677 Vertebral Artery Dissection | DRC | 1 | 1.248.1317 Mycoplasma | DRC | 2 | ||
| 1.111.162 Hepatocellular Carcinoma | DRC | 1 | 1.248.1317 Mycoplasma | IRC | 1 | ||
| 1.117.1309 Acetaminophen | DRC | 1 | 1.248.1683 Syphilis | no_coll | 1 | ||
| 1.117.1389 Bilirubin | DRC | 57 | 1.248.2104 Trichomonas Vaginalis | IRC | 3 | ||
| 1.117.1389 Bilirubin | IRC | 34 | 1.248.655 Chlamydia Trachomatis | DRC | 4 | ||
| 1.120.384 Gut Microbiota | DRC | 2 | 1.248.655 Chlamydia Trachomatis | IRC | 9 | ||
| 1.120.384 Gut Microbiota | IRC | 3 | 1.257.983 Hydrocephalus | IRC | 3 | ||
| 1.120.384 Gut Microbiota | no_coll | 1 | 1.258.1958 Leptospirosis | IRC | 2 | ||
| 1.125.1718 Hepatitis E Virus | DRC | 2 | 1.258.227 Lyme Disease | IRC | 1 | ||
| 1.125.1718 Hepatitis E Virus | IRC | 9 | 1.26.107 Adiponectin | DRC | 1 | ||
| 1.125.275 HBV | DRC | 2 | 1.26.337 Leptin | DRC | 1 | ||
| 1.125.275 HBV | IRC | 1 | 1.261.596 Trypanosoma Cruzi | DRC | 1 | ||
| 1.125.83 HCV | DRC | 1 | 1.266.1068 Pressure Ulcer | IRC | 1 | ||
| 1.125.83 HCV | IRC | 1 | 1.278.1796 Neuroblastoma | DRC | 1 | ||
| 1.127.1303 Endothelin | IRC | 1 | 1.281.1236 Amyloidosis | IRC | 1 | ||
| 1.128.1489 Hysteroscopy | DRC | 1 | 1.286.845 Complement | DRC | 1 | ||
| 1.128.1521 Ectopic Pregnancy | DRC | 1 | 1.286.845 Complement | IRC | 1 | ||
| 1.128.482 Contraception | DRC | 1 | 1.324.2020 Tetanus | DRC | 1 | ||
| 1.128.482 Contraception | IRC | 2 | 1.34.1657 Elbow | DRC | 1 | ||
| 1.132.2267 Clubfoot | IRC | 1 | 1.36.2059 Retinopathy Of Prematurity | DRC | 1 | ||
| 1.132.759 Matrix Metalloproteinases | DRC | 1 | 1.37.309 Congenital Heart Disease | DRC | 1 | ||
| 1.136.1749 Down Syndrome | DRC | 1 | 1.37.309 Congenital Heart Disease | IRC | 2 | ||
| 1.136.1780 Family Quality Of Life | IRC | 1 | 1.37.467 Echocardiography | DRC | 1 | ||
| 1.136.283 Autism | DRC | 1 | 1.42.545 STEC | DRC | 1 | ||
| 1.137.217 Melatonin | DRC | 3 | 1.42.545 STEC | IRC | 1 | ||
| 1.137.217 Melatonin | IRC | 1 | 1.42.678 Listeria Monocytogenes | DRC | 3 | ||
| 1.14.1293 Emergency Department | IRC | 1 | 1.42.678 Listeria Monocytogenes | IRC | 1 | ||
| 1.14.1359 Interprofessional Education | DRC | 1 | 1.44.1198 Food Insecurity | DRC | 1 | ||
| 1.141.407 Acute Promyelocytic Leukemia | DRC | 1 | 1.44.1198 Food Insecurity | IRC | 18 | ||
| 1.141.407 Acute Promyelocytic Leukemia | IRC | 1 | 1.49.1061 Endodontics | IRC | 1 | ||
| 1.142.1628 Urinary Diversion | DRC | 1 | 1.49.468 Oral Health | DRC | 5 | ||
| 1.142.832 Fecal Incontinence | DRC | 1 | 1.49.468 Oral Health | IRC | 5 | ||
| 1.142.832 Fecal Incontinence | no_coll | 1 | 1.5.1674 Ketogenic Diet | DRC | 1 | ||
| 1.148.94 Candida Albicans | DRC | 4 | 1.5.420 Cortisol | IRC | 1 | ||
| 1.148.94 Candida Albicans | IRC | 1 | 1.54.1401 Genome Editing | IRC | 1 | ||
| 1.150.1148 Deaf | DRC | 5 | 1.54.958 HMGB1 | IRC | 1 | ||
| 1.150.1148 Deaf | IRC | 1 | 1.55.1904 ACE Gene | DRC | 1 | ||
| 1.150.1148 Deaf | no_coll | 2 | 1.55.830 Acute Kidney Injury | DRC | 6 | ||
| 1.151.222 Laparoscopic Cholecystectomy | DRC | 4 | 1.6.1437 Common Variable Immunodeficiency | no_coll | 1 | ||
| 1.151.222 Laparoscopic Cholecystectomy | IRC | 1 | 1.6.351 Endotoxin | DRC | 1 | ||
| 1.154.1057 Pulmonary Surfactant | DRC | 2 | 1.6.351 Endotoxin | IRC | 1 | ||
| 1.154.1057 Pulmonary Surfactant | IRC | 6 | 1.6.452 Somatic Hypermutation | DRC | 1 | ||
| 1.154.1057 Pulmonary Surfactant | no_coll | 1 | 1.6.609 Toll-like Receptors | DRC | 1 | ||
| 1.154.1088 Intensive Care | DRC | 1 | 1.65.192 COPD | IRC | 1 | ||
| 1.154.277 Mechanical Ventilation | DRC | 1 | 1.66.11 HIV Prevalence & Prophylaxis | DRC | 12 | ||
| 1.154.360 Procalcitonin | DRC | 1 | 1.66.11 HIV Prevalence & Prophylaxis | IRC | 37 | ||
| 1.154.360 Procalcitonin | IRC | 3 | 1.66.1615 Aids Dementia Complex | IRC | 1 | ||
| 1.155.598 Informed Consent | IRC | 1 | 1.68.256 Docosahexaenoic Acid | DRC | 1 | ||
| 1.156.2047 Global Surgery | DRC | 1 | 1.68.707 Alpha-Tocopherol | IRC | 1 | ||
| 1.156.2047 Global Surgery | IRC | 7 | 1.71.2048 Mean Platelet Volume | DRC | 1 | ||
| 1.156.381 Maternal Mortality | DRC | 47 | 1.72.1072 Postpartum Depression | DRC | 2 | ||
| 1.156.381 Maternal Mortality | IRC | 144 | 1.72.1072 Postpartum Depression | IRC | 9 | ||
| 1.156.381 Maternal Mortality | no_coll | 3 | 1.72.1710 Postpartum Hemorrhage | DRC | 1 | ||
| 1.157.728 Biliary Atresia | DRC | 8 | 1.72.1732 Patent Ductus Arteriosus | DRC | 21 | ||
| 1.158.2138 Porokeratosis | DRC | 1 | 1.72.1732 Patent Ductus Arteriosus | IRC | 4 | ||
| 1.161.315 HSV-1 | IRC | 2 | 1.72.1745 Hyperemesis Gravidarum | DRC | 2 | ||
| 1.161.711 Cytomegalovirus | DRC | 2 | 1.72.1745 Hyperemesis Gravidarum | IRC | 1 | ||
| 1.161.711 Cytomegalovirus | IRC | 1 | 1.72.182 Gestational Diabetes Mellitus | DRC | 23 | ||
| 1.161.711 Cytomegalovirus | no_coll | 1 | 1.72.182 Gestational Diabetes Mellitus | IRC | 65 | ||
| 1.163.446 Schistosomiasis | IRC | 1 | 1.72.182 Gestational Diabetes Mellitus | no_coll | 2 | ||
| 1.164.1871 Menarche | DRC | 1 | 1.72.531 Preeclampsia | DRC | 36 | ||
| 1.168.671 Vascular Access | DRC | 1 | 1.72.531 Preeclampsia | IRC | 22 | ||
| 1.179.108 Human Papillomavirus | IRC | 1 | 1.72.531 Preeclampsia | no_coll | 2 | ||
| 1.184.1030 Erythropoietin | DRC | 1 | 1.72.748 Preterm Infants | DRC | 10 | ||
| 1.184.573 Iron Overload | IRC | 13 | 1.72.748 Preterm Infants | IRC | 13 | ||
| 1.184.653 Zinc | DRC | 1 | 1.72.808 Breech Presentation | DRC | 9 | ||
| 1.186.1008 Nuchal Translucency | DRC | 1 | 1.72.808 Breech Presentation | IRC | 8 | ||
| 1.186.948 Digeorge Syndrome | DRC | 1 | 1.72.891 Breastfeeding | DRC | 7 | ||
| 1.194.273 Mycobacterium Tuberculosis & Leprosy | DRC | 1 | 1.72.891 Breastfeeding | IRC | 5 | ||
| 1.194.273 Mycobacterium Tuberculosis & Leprosy | IRC | 2 | 1.72.922 Fetal Heart Rate | DRC | 18 | ||
| 1.195.1341 Enteric Nervous System | DRC | 1 | 1.72.922 Fetal Heart Rate | IRC | 19 | ||
| 1.199.1048 Pleurodesis | DRC | 1 | 1.72.922 Fetal Heart Rate | no_coll | 1 | ||
| 1.213.168 Hypothyroidism | DRC | 1 | 1.72.924 Preterm Labor | DRC | 34 | ||
| 1.216.1563 Volvulus | DRC | 1 | 1.72.924 Preterm Labor | IRC | 30 | ||
| 1.216.1563 Volvulus | IRC | 2 | 1.75.326 Antiphospholipid Syndrome | DRC | 7 | ||
| 1.216.1996 Pneumomediastinum | DRC | 3 | 1.75.326 Antiphospholipid Syndrome | IRC | 1 | ||
| 1.216.2098 Intussusception | DRC | 1 | 1.80.279 Vitamin D | DRC | 6 | ||
| 1.216.2287 Gastroschisis | DRC | 12 | 1.80.279 Vitamin D | IRC | 5 | ||
| 1.216.2287 Gastroschisis | IRC | 6 | 1.81.1272 HLA-G | DRC | 2 | ||
| 1.216.2287 Gastroschisis | no_coll | 2 | 1.81.1408 Fertility Preservation | DRC | 2 | ||
| 1.217.1038 Toxoplasma Gondii | IRC | 1 | 1.81.979 Twin-Twin Transfusion Syndrome | DRC | 5 | ||
| 1.217.59 Malaria | DRC | 11 | 1.81.979 Twin-Twin Transfusion Syndrome | IRC | 2 | ||
| 1.217.59 Malaria | IRC | 28 | 1.81.979 Twin-Twin Transfusion Syndrome | no_coll | 1 | ||
| 1.217.59 Malaria | no_coll | 1 | 1.82.1066 Cerebral Palsy | DRC | 3 | ||
| 1.222.143 Epilepsy | IRC | 2 | 1.82.1066 Cerebral Palsy | IRC | 1 | ||
| 1.222.143 Epilepsy | no_coll | 1 | 1.82.1298 Spinal Cord Injury Rehabilitation | IRC | 1 | ||
| 1.225.1476 Alloimmunization | DRC | 1 | 1.94.1664 VKORC1 | DRC | 1 | ||
| 1.225.2074 Methemoglobinemia | DRC | 5 | 1.95.387 Helicobacter Pylori | DRC | 1 | ||
| 1.225.2074 Methemoglobinemia | IRC | 5 | 1.95.723 Irritable Bowel Syndrome | DRC | 2 | ||
| 1.225.626 Sickle Cell Disease | DRC | 4 | 1.95.723 Irritable Bowel Syndrome | IRC | 1 | ||
| 1.225.626 Sickle Cell Disease | IRC | 1 | 1.95.801 Cimetidine | IRC | 1 | ||
| 1.225.786 Spectrin | DRC | 1 | 3.16.1496 Ethnobotany | DRC | 1 | ||
| 1.228.200 Dengue | DRC | 1 | 3.171.1011 Carotenoids | DRC | 1 | ||
| 1.228.200 Dengue | no_coll | 1 | 3.180.2418 Alginate Lyase | DRC | 1 | ||
| 1.228.994 Ebola Virus | DRC | 1 | 3.198.400 Mycotoxins | IRC | 1 | ||
| 1.228.994 Ebola Virus | IRC | 1 | 3.91.496 Cadmium | DRC | 1 | ||
| 1.23.1036 Surgical Site Infection | DRC | 2 | 3.91.920 Selenium | DRC | 1 | ||
| 1.23.1397 Urinary Tract Infection | DRC | 1 | 3.91.920 Selenium | IRC | 2 | ||
| 1.23.146 Antibiotic Resistance | DRC | 5 | 4.61.1124 Rough Sets | IRC | 2 | ||
| 1.23.146 Antibiotic Resistance | IRC | 16 | 6.146.734 Anthropology | IRC | 1 | ||
| 1.23.173 Staphylococcus Aureus | DRC | 1 | 6.178.516 Divorce | IRC | 2 | ||
| 1.23.173 Staphylococcus Aureus | IRC | 3 | 6.24.858 Intimate Partner Violence | DRC | 1 | ||
| 1.23.1757 Group B Streptococcus | DRC | 72 | 6.24.858 Intimate Partner Violence | IRC | 2 | ||
| 1.23.1757 Group B Streptococcus | IRC | 53 | 6.73.2331 Health Locus of Control | IRC | 1 | ||
| 1.23.1757 Group B Streptococcus | no_coll | 3 | 8.124.1648 Heat Waves | IRC | 1 | ||
| 1.23.422 Gentamicin | DRC | 1 | 8.124.552 Air Pollution | DRC | 4 | ||
| 1.23.422 Gentamicin | IRC | 1 | 8.124.552 Air Pollution | IRC | 3 | ||
| 1.23.714 Neisseria Meningitidis | DRC | 1 | |||||
Table 16.
Impact of the articles by topic and type of collaboration for the full period. Note: For various topics, the total number of articles is below 20.
Table 16.
Impact of the articles by topic and type of collaboration for the full period. Note: For various topics, the total number of articles is below 20.
| Topic | Collaboration | CNCI (median) |
|---|---|---|
| 1.100.1284 Fetal Alcohol Syndrome | DRC | 1.536 |
| 1.103.1225 ITP | DRC | 0.318 |
| 1.103.1225 ITP | IRC | 0.227 |
| 1.104.126 Influenza | DRC | 0.225 |
| 1.104.126 Influenza | IRC | 4.503 |
| 1.104.1770 Pertussis | IRC | 0.924 |
| 1.104.901 Foot-And-Mouth Disease Virus | IRC | 1.438 |
| 1.104.975 Respiratory Syncytial Virus | DRC | 0.000 |
| 1.104.975 Respiratory Syncytial Virus | IRC | 1.675 |
| 1.105.1677 Vertebral Artery Dissection | DRC | 0.978 |
| 1.111.162 Hepatocellular Carcinoma | DRC | 0.197 |
| 1.117.1309 Acetaminophen | DRC | 0.178 |
| 1.117.1389 Bilirubin | DRC | 0.554 |
| 1.117.1389 Bilirubin | IRC | 1.561 |
| 1.120.384 Gut Microbiota | DRC | 0.224 |
| 1.120.384 Gut Microbiota | IRC | 1.265 |
| 1.125.1718 Hepatitis E Virus | DRC | 0.384 |
| 1.125.1718 Hepatitis E Virus | IRC | 1.062 |
| 1.125.275 HBV | DRC | 0.129 |
| 1.125.275 HBV | IRC | 0.000 |
| 1.125.83 HCV | DRC | 0.546 |
| 1.125.83 HCV | IRC | 1.320 |
| 1.127.1303 Endothelin | IRC | 0.810 |
| 1.128.1489 Hysteroscopy | DRC | 0.287 |
| 1.128.1521 Ectopic Pregnancy | DRC | 3.365 |
| 1.128.482 Contraception | DRC | 0.315 |
| 1.128.482 Contraception | IRC | 0.204 |
| 1.132.2267 Clubfoot | IRC | 1.649 |
| 1.132.759 Matrix Metalloproteinases | DRC | 1.198 |
| 1.136.1749 Down Syndrome | DRC | 0.225 |
| 1.136.1780 Family Quality Of Life | IRC | 0.931 |
| 1.136.283 Autism | DRC | 0.301 |
| 1.137.217 Melatonin | DRC | 0.799 |
| 1.137.217 Melatonin | IRC | 0.253 |
| 1.14.1293 Emergency Department | IRC | 0.192 |
| 1.14.1359 Interprofessional Education | DRC | 0.637 |
| 1.141.407 Acute Promyelocytic Leukemia | DRC | 2.227 |
| 1.141.407 Acute Promyelocytic Leukemia | IRC | 0.278 |
| 1.142.1628 Urinary Diversion | DRC | 0.965 |
| 1.142.832 Fecal Incontinence | DRC | 2.110 |
| 1.148.94 Candida Albicans | DRC | 0.736 |
| 1.148.94 Candida Albicans | IRC | 1.067 |
| 1.150.1148 Deaf | DRC | 0.848 |
| 1.150.1148 Deaf | IRC | 0.854 |
| 1.151.222 Laparoscopic Cholecystectomy | DRC | 0.029 |
| 1.151.222 Laparoscopic Cholecystectomy | IRC | 0.193 |
| 1.154.1057 Pulmonary Surfactant | DRC | 0.138 |
| 1.154.1057 Pulmonary Surfactant | IRC | 0.548 |
| 1.154.1088 Intensive Care | DRC | 0.144 |
| 1.154.277 Mechanical Ventilation | DRC | 0.037 |
| 1.154.360 Procalcitonin | DRC | 1.875 |
| 1.154.360 Procalcitonin | IRC | 0.656 |
| 1.155.598 Informed Consent | IRC | 0.495 |
| 1.156.2047 Global Surgery | DRC | 0.409 |
| 1.156.2047 Global Surgery | IRC | 1.760 |
| 1.156.381 Maternal Mortality | DRC | 0.518 |
| 1.156.381 Maternal Mortality | IRC | 1.059 |
| 1.157.728 Biliary Atresia | DRC | 0.279 |
| 1.158.2138 Porokeratosis | DRC | 1.291 |
| 1.161.315 HSV-1 | IRC | 0.625 |
| 1.161.711 Cytomegalovirus | DRC | 0.095 |
| 1.161.711 Cytomegalovirus | IRC | 2.382 |
| 1.163.446 Schistosomiasis | IRC | 2.650 |
| 1.164.1871 Menarche | DRC | 0.271 |
| 1.168.671 Vascular Access | DRC | 0.337 |
| 1.179.108 Human Papillomavirus | IRC | 0.776 |
| 1.184.1030 Erythropoietin | DRC | 0.056 |
| 1.184.573 Iron Overload | IRC | 1.267 |
| 1.184.653 Zinc | DRC | 1.264 |
| 1.186.1008 Nuchal Translucency | DRC | 1.270 |
| 1.186.948 Digeorge Syndrome | DRC | 0.070 |
| 1.194.273 Mycobacterium Tuberculosis & Leprosy | DRC | 0.757 |
| 1.194.273 Mycobacterium Tuberculosis & Leprosy | IRC | 7.416 |
| 1.195.1341 Enteric Nervous System | DRC | 0.590 |
| 1.199.1048 Pleurodesis | DRC | 0.857 |
| 1.213.168 Hypothyroidism | DRC | 0.000 |
| 1.216.1563 Volvulus | DRC | 1.147 |
| 1.216.1563 Volvulus | IRC | 0.895 |
| 1.216.1996 Pneumomediastinum | DRC | 0.266 |
| 1.216.2098 Intussusception | DRC | 0.134 |
| 1.216.2287 Gastroschisis | DRC | 0.546 |
| 1.216.2287 Gastroschisis | IRC | 1.876 |
| 1.217.1038 Toxoplasma Gondii | IRC | 0.755 |
| 1.217.59 Malaria | DRC | 0.491 |
| 1.217.59 Malaria | IRC | 1.331 |
| 1.222.143 Epilepsy | IRC | 1.278 |
| 1.225.1476 Alloimmunization | DRC | 0.492 |
| 1.225.2074 Methemoglobinemia | DRC | 0.851 |
| 1.225.2074 Methemoglobinemia | IRC | 1.007 |
| 1.225.626 Sickle Cell Disease | DRC | 0.330 |
| 1.225.626 Sickle Cell Disease | IRC | 1.752 |
| 1.225.786 Spectrin | DRC | 0.000 |
| 1.228.200 Dengue | DRC | 1.134 |
| 1.228.994 Ebola Virus | DRC | 0.165 |
| 1.228.994 Ebola Virus | IRC | 0.495 |
| 1.23.1036 Surgical Site Infection | DRC | 0.355 |
| 1.23.1397 Urinary Tract Infection | DRC | 0.704 |
| 1.23.146 Antibiotic Resistance | DRC | 0.621 |
| 1.23.146 Antibiotic Resistance | IRC | 1.050 |
| 1.23.173 Staphylococcus Aureus | DRC | 0.223 |
| 1.23.173 Staphylococcus Aureus | IRC | 0.521 |
| 1.23.1757 Group B Streptococcus | DRC | 0.790 |
| 1.23.1757 Group B Streptococcus | IRC | 0.878 |
| 1.23.422 Gentamicin | DRC | 0.628 |
| 1.23.422 Gentamicin | IRC | 0.401 |
| 1.23.714 Neisseria Meningitidis | DRC | 0.000 |
| 1.231.432 Homocysteine | DRC | 0.625 |
| 1.231.432 Homocysteine | IRC | 1.080 |
| 1.235.1617 Deglutition | DRC | 0.324 |
| 1.235.1679 Foreign Body | IRC | 0.471 |
| 1.236.1155 Capsule Endoscopy | DRC | 0.325 |
| 1.236.312 Portal Hypertension | DRC | 0.000 |
| 1.243.1012 Vesicoureteral Reflux | DRC | 0.621 |
| 1.246.710 Rotavirus | DRC | 0.620 |
| 1.248.1317 Mycoplasma | DRC | 0.468 |
| 1.248.1317 Mycoplasma | IRC | 1.670 |
| 1.248.2104 Trichomonas Vaginalis | IRC | 0.983 |
| 1.248.655 Chlamydia Trachomatis | DRC | 0.772 |
| 1.248.655 Chlamydia Trachomatis | IRC | 1.343 |
| 1.257.983 Hydrocephalus | IRC | 1.570 |
| 1.258.1958 Leptospirosis | IRC | 0.373 |
| 1.258.227 Lyme Disease | IRC | 3.590 |
| 1.26.107 Adiponectin | DRC | 0.631 |
| 1.26.337 Leptin | DRC | 0.794 |
| 1.261.596 Trypanosoma Cruzi | DRC | 0.286 |
| 1.266.1068 Pressure Ulcer | IRC | 1.124 |
| 1.278.1796 Neuroblastoma | DRC | 0.057 |
| 1.281.1236 Amyloidosis | IRC | 0.816 |
| 1.286.845 Complement | DRC | 0.384 |
| 1.286.845 Complement | IRC | 0.193 |
| 1.324.2020 Tetanus | DRC | 0.766 |
| 1.34.1657 Elbow | DRC | 0.071 |
| 1.36.2059 Retinopathy Of Prematurity | DRC | 0.599 |
| 1.37.309 Congenital Heart Disease | DRC | 0.720 |
| 1.37.309 Congenital Heart Disease | IRC | 2.058 |
| 1.37.467 Echocardiography | DRC | 0.380 |
| 1.42.545 STEC | DRC | 0.000 |
| 1.42.545 STEC | IRC | 1.210 |
| 1.42.678 Listeria Monocytogenes | DRC | 0.331 |
| 1.42.678 Listeria Monocytogenes | IRC | 0.163 |
| 1.44.1198 Food Insecurity | DRC | 0.025 |
| 1.44.1198 Food Insecurity | IRC | 1.269 |
| 1.49.1061 Endodontics | IRC | 1.046 |
| 1.49.468 Oral Health | DRC | 1.001 |
| 1.49.468 Oral Health | IRC | 1.425 |
| 1.5.1674 Ketogenic Diet | DRC | 0.000 |
| 1.5.420 Cortisol | IRC | 1.267 |
| 1.54.1401 Genome Editing | IRC | 0.923 |
| 1.54.958 HMGB1 | IRC | 0.784 |
| 1.55.1904 ACE Gene | DRC | 0.229 |
| 1.55.830 Acute Kidney Injury | DRC | 0.213 |
| 1.6.351 Endotoxin | DRC | 0.890 |
| 1.6.351 Endotoxin | IRC | 0.936 |
| 1.6.452 Somatic Hypermutation | DRC | 0.000 |
| 1.6.609 Toll-like Receptors | DRC | 0.165 |
| 1.65.192 COPD | IRC | 187.114 |
| 1.66.11 HIV Prevalence & Prophylaxis | DRC | 0.346 |
| 1.66.11 HIV Prevalence & Prophylaxis | IRC | 1.884 |
| 1.66.1615 Aids Dementia Complex | IRC | 4.164 |
| 1.68.256 Docosahexaenoic Acid | DRC | 0.625 |
| 1.68.707 Alpha-Tocopherol | IRC | 1.361 |
| 1.71.2048 Mean Platelet Volume | DRC | 0.405 |
| 1.72.1072 Postpartum Depression | DRC | 2.411 |
| 1.72.1072 Postpartum Depression | IRC | 0.953 |
| 1.72.1710 Postpartum Hemorrhage | DRC | 0.000 |
| 1.72.1732 Patent Ductus Arteriosus | DRC | 0.586 |
| 1.72.1732 Patent Ductus Arteriosus | IRC | 0.571 |
| 1.72.1745 Hyperemesis Gravidarum | DRC | 0.295 |
| 1.72.1745 Hyperemesis Gravidarum | IRC | 0.731 |
| 1.72.182 Gestational Diabetes Mellitus | DRC | 0.799 |
| 1.72.182 Gestational Diabetes Mellitus | IRC | 0.927 |
| 1.72.531 Preeclampsia | DRC | 0.402 |
| 1.72.531 Preeclampsia | IRC | 1.026 |
| 1.72.748 Preterm Infants | DRC | 0.183 |
| 1.72.748 Preterm Infants | IRC | 0.918 |
| 1.72.808 Breech Presentation | DRC | 0.428 |
| 1.72.808 Breech Presentation | IRC | 1.143 |
| 1.72.891 Breastfeeding | DRC | 0.643 |
| 1.72.891 Breastfeeding | IRC | 1.024 |
| 1.72.922 Fetal Heart Rate | DRC | 0.555 |
| 1.72.922 Fetal Heart Rate | IRC | 0.883 |
| 1.72.924 Preterm Labor | DRC | 0.552 |
| 1.72.924 Preterm Labor | IRC | 1.029 |
| 1.75.326 Antiphospholipid Syndrome | DRC | 0.904 |
| 1.75.326 Antiphospholipid Syndrome | IRC | 0.297 |
| 1.80.279 Vitamin D | DRC | 0.669 |
| 1.80.279 Vitamin D | IRC | 0.611 |
| 1.81.1272 HLA-G | DRC | 0.554 |
| 1.81.1408 Fertility Preservation | DRC | 0.559 |
| 1.81.979 Twin-Twin Transfusion Syndrome | DRC | 0.260 |
| 1.81.979 Twin-Twin Transfusion Syndrome | IRC | 2.834 |
| 1.82.1066 Cerebral Palsy | DRC | 0.667 |
| 1.82.1066 Cerebral Palsy | IRC | 0.741 |
| 1.82.1298 Spinal Cord Injury Rehabilitation | IRC | 3.041 |
| 1.94.1664 VKORC1 | DRC | 0.081 |
| 1.95.387 Helicobacter Pylori | DRC | 0.466 |
| 1.95.723 Irritable Bowel Syndrome | DRC | 0.531 |
| 1.95.723 Irritable Bowel Syndrome | IRC | 0.721 |
| 1.95.801 Cimetidine | IRC | 0.233 |
| 3.16.1496 Ethnobotany | DRC | 0.658 |
| 3.171.1011 Carotenoids | DRC | 0.531 |
| 3.180.2418 Alginate Lyase | DRC | 0.425 |
| 3.198.400 Mycotoxins | IRC | 3.158 |
| 3.91.496 Cadmium | DRC | 0.000 |
| 3.91.920 Selenium | DRC | 0.119 |
| 3.91.920 Selenium | IRC | 0.425 |
| 4.61.1124 Rough Sets | IRC | 0.777 |
| 6.146.734 Anthropology | IRC | 2.034 |
| 6.178.516 Divorce | IRC | 2.074 |
| 6.24.858 Intimate Partner Violence | DRC | 7.091 |
| 6.24.858 Intimate Partner Violence | IRC | 3.483 |
| 6.73.2331 Health Locus of Control | IRC | 2.211 |
| 8.124.1648 Heat Waves | IRC | 0.666 |
| 8.124.552 Air Pollution | DRC | 0.126 |
| 8.124.552 Air Pollution | IRC | 0.631 |
Acronyms- Universities
| University | Acronyms | University | Acronyms |
| A.T. Still Univ | ATSU-USA | Ljubljana Univ Medical Centre | Ljubliana UMC-SVN |
| Aalborg Univ | AAU-DNK | Lome Univ | UL-TGO |
| Aarhus Univ | AU-DNK | London Univ | UoL-GBR |
| Aberta Univ | UAb-PRT | Lorraine Univ | UL-FRA |
| Abomey Calavi Univ | UAC-BEN | Los Andes Univ | UANDES-CHL |
| Abuja Univ | UNIABUJA-NGA | Loughborough Univ | Lboro-GBR |
| Addis Ababa Univ | AAU-ETH | Louisiana State Univ | LSU-system-USA |
| Adelaid Univ | AU-AUS | Louisville Univ | UofL-USA |
| Adigrat Univ | AGU-ETH | Loyola Univ Chicago | LUC-USA |
| Aga Khan Univ | AKU-KEN | Lubumbashi Univ | UNILU-ZAR |
| Aga Khan Univ | AKU-PAK | Ludwig Maximilians Univ Munich | LMU Munich-DEU |
| Aga Khan Univ | AKU-TZA | Lund Univ | LU-SWE |
| Ahfad Univ for Women | AUW-SDN | Lusaka Apex Medical Univ | LAMU-ZMB |
| Ahmadu Bello Univ | ABU-NGA | Maastricht Univ | UM-NLD |
| Ain Shams Univ | ASU-EGY | Macquarie Univ | MQ-AUS |
| Al Azhar Univ | Al-Zahar-EGY | Madda Walabu Univ | MWU-ETH |
| Al Neelain Univ | Al Neelain-SDN | Mahajanga Univ | UMGA-MDG |
| Alabama Univ | UA-System-USA | Maharashtra Univ of Health Sciences | MUHS-IND |
| Alazar Univ | AI-Azar-EGY | Mahidol Univ | UM-THA |
| Albert Einstein College of Medicine | Einstein-USA | Maiduguri Univ | UNIMAID-NGA |
| Alberta Univ | UAlberta-CAN | Makerere Univ | Mak-UGA |
| Alborz Univ of Medical Sciences | ABZUMS-IRN | Malawi Univ | UNIMA-MWI |
| Aleppo Univ | ALEPUNIV-SYR | Malawi Univ of Science and Technology | MUST-MWI |
| Alexandria Univ | AU-EGY | Malaya Univ | UM-MYS |
| Alfaisal Univ | AU-SAU | Management & Technology Univ | UMT-PAK |
| Ambo Univ | AU-ETH | Manchester Univ | UM-GBR |
| Amer Univ Beirut | UAB-LBN | Manitoba Univ | UManitoba-CAN |
| Amrita Univ | AU-IND | Mansoura Univ | MA-EGY |
| Amsterdam Univ | UvA-NLD | MARA Technological Univ | UiTM-MYS |
| Anglia Ruskin Univ | ARU-GBR | Maragheh Univ of Medical Sciences | MUMS-IRN |
| Ankara Yıldırım Beyazıt Univ | AYBU-TUR | Marmara Univ | UM-TUR |
| Antwerp Univ | UAntwerp-BEL | Marshall Univ | UM-USA |
| Applied Science Private Univ | ASU-JOR | Martin Luther Univ Halle-Wittenberg | MLU-DEU |
| Arabian Gulf Univ | AGU-BHR | Maseno Univ | MSU-KEN |
| Arak Univ of Medical Sciences | AUMS-IRN | Massachusetts Univ | UMass-System-USA |
| Arba Minch Univ | AMU-ETH | Mazandaran Univ of Medical Sciences | MazUMS-IRN |
| Arizona Univ | UofA-USA | Mbarara Univ of Science & Technology | MUST-UGA |
| Arkansas State Univ | ASU-System-USA | McGill Univ | McGill-CAN |
| Arkansas Univ | UofA-System-USA | McMaster Univ | McMaster-CAN |
| Assiut Univ | AUN-EGY | Medical Sciences Univ | UNIMED-NGA |
| Ateneo de Manila Univ | Ateneo-PHL | Medical Univ of Lodz | MUL-POL |
| Auckland Univ | UoA-NZL | Medical Univ Vienna | MedUni Vienna-AUT |
| Auckland Univ of Technology | AUT-NZL | Mekelle Univ | MU-ETH |
| Australian Catholic Univ | ACU-AUS | Melbourne Univ | UNIMELB-AUS |
| Australian National Univ | ANU-AUS | Menoufia Univ | UM-EGY |
| Autonoma Chile univ | Uautonoma-CHL | Messina Univ | UniME-ITA |
| Autonomous Univ of Madrid | UAM-ESP | Metropolitan Autonomous Univ | UAM-MEX |
| Baba Farid Univ of Health Sciences | BFUHS-IND | Miami Univ | UMiami-USA |
| Baghdad College of Medical Sciences | BCMS-IRQ | Michigan State Univ | MSU-USA |
| Bahir Dar Univ | BDU-ETH | Michigan Univ | UMich-System-USA |
| Balamand Univ | UOB-LBN | Milan Univ | UNIMI-ITA |
| Ball State Univ | BSU-USA | Minia Univ | Minia-EGY |
| Bamako Univ | BU-MLI | Minnesota Univ | UofM-System-USA |
| Banaras Hindu Univ | BHU-IND | Misr Univ for Science and Technology | MUST-EGY |
| Bangabandhu Sheikh Mujib Medical Univ | BSMMU-BGD | Missouri Univ | UM-System-USA |
| Baqiyatallah Univ of Medical Sciences | BMSU-IRN | Mizan Tepi Univ | MTU-ETH |
| Barcelona Univ | UB-ESP | Mohammed V Univ | Mohammed V-MAR |
| Bari Univ | UniBa-ITA | Moi Univ | MU-KEN |
| Basel Univ | UB-CHE | Monash Univ | UM-AUS |
| Bath Univ | UBath-GBR | Monastir Univ | UM-TUN |
| Bayero Univ | BUK-NGA | Montpellier Univ | UMontpellier-FRA |
| Baylor College Medicine | BCM-USA | Montreal Univ | UdeM-CAN |
| Baylor Univ | UB-USA | Morehouse School of Medicine | MSM-USA |
| Belgrade Univ | UB-SRB | Moscow State Univ of Medicine and Dentistry | MSUMD-RUS |
| Benghazi Univ | UB-LBY | Mountains of the Moon Univ | MMU-UGA |
| Benha Univ | BU-EGY | Muhimbili Univ of Health and Allied Sciences | MUHAS-TZA |
| Beni Suef Univ | BSU-EGY | Nacional de Colombia Univ | UNAL-COL |
| Benin Univ | UNIBEN-NGA | Nagoya City Univ | NCU-JPN |
| Bergen Univ | UiB-NOR | Nairobi Univ | UoN-KEN |
| Bhaikaka Univ | BU-IND | Nanjing Univ | NJU-CHN |
| Bielefeld Univ | Uni Bielefeld-DEU | Nanyang Technological Univ | NTU-SGP |
| Birmingham Univ | BU-GBR | Nara Medical Univ | NMU-JPN |
| BLDE Univ | BLDE Univ-IND | National Research Univ Higher School of Economics | HSE Univ-RUS |
| Bologna Univ | UNIBO-ITA | National School of Public Health of Spain | ENS-ESP |
| Bordeaux Segalen Univ | BSU-FRA | National Univ of Malaysia | UKM-MYS |
| Bordeaux Univ | UBordeaux-FRA | National Univ of Singapore | NUS-SGP |
| Boston Univ | BU-USA | Nazi Boni Univ | UNB-BFA |
| Botswana Univ | UB-BWA | Nebraska Univ | NU-System-USA |
| Bowen Univ | BU-NGA | New Mexico Univ | UNM-USA |
| Brandeis Univ | UBrandeis-USA | New South Wales Univ | UNSW-AUS |
| Brasilia Univ | UnB-BRA | New York Univ | NYU-USA |
| Brigham Young Univ | BYU-USA | Newcastle Univ | Newcastle Univ-GBR |
| Brighton and Sussex Medical School | BSMS-GBR | Nigeria Univ | UNN-NGA |
| Bristol Univ | UB-GBR | Nnamdi Azikiwe Univ | UNIZIK-NGA |
| British Columbia Univ | UBC-CAN | North Carolina Univ | UNC-System-USA |
| Brown Univ | UBrown-USA | Northeastern Univ | NEU-USA |
| Bucharest Univ of Economic Studies | ASE-ROM | Northumbria Univ | NU-GBR |
| Burgundy Univ | UB-FRA | North-West Univ | NWU-ZAF |
| Busitema Univ | BU-UGA | Northwestern Univ | NU-USA |
| Cagliari Univ | UNICA-ITA | Obafemi Awolowo Univ | OAU-NGA |
| Cairo Univ | CU-EGY | Occupational and Environmental Health Univ | UOEH-JPN |
| Calabar Univ | UNICAL-NGA | Odisha Univ of Health Science | OUHS-IND |
| Calgary Univ | UCalgary-CAN | Oklahoma State Univ System | OSU-System-USA |
| California State Univ | Cal State-USA | Olabisi Onabanjo Univ | OOU-NGA |
| California Univ | UC-System-USA | Oregon Health & Science Univ | OHSU-USA |
| California Univ of Science and Medicine | CUSM-USA | Oslo Univ | UiO-NOR |
| Cambridge Univ | CAM-GBR | Otago Univ | UO-NZL |
| Can Tho Univ of Medicine and Pharmacy | CTUMP-VNM | Ottawa Univ | uOttawa-CAN |
| Canberra Univ | UC-AUS | Ouagadougou Univ | UO-BFA |
| Canterbury Univ | UC-NZL | Oulu Univ | UniOulu -FIN |
| Cape Coast Univ | UCC-GHA | Oxford Univ | OX-GBR |
| Cape Peninsula Univ of Technology | CPUT-ZAF | Oxford Univ Clinical Research Unit in Vietnam | OUCRU-VNM |
| Cape Town Univ | UCT-ZAF | Padua Univ | UniPD-ITA |
| Capital Medical Univ | CCMU-CHN | Papua New Guinea Univ | UPNG -PNG |
| Carol Davila Univ of Medicine and Pharmacy | UMFCD-ROM | Paris 05 Univ | Paris V-FRA |
| Cartagena Univ | UNICARTAGENA-COL | Paris 06 Univ | UPMC-FRA |
| Carthage Univ | UCAR-TUN | Paris 11 Univ | Paris XI-FRA |
| Case Western Reserve Univ | CWRU-USA | Parma Univ | UNIPR-ITA |
| Catholic Univ of Graben | UCG-ZAR | Pavia Univ | UNIPV-ITA |
| Catholic Univ of Health and Allied Sciences | CUHAS-TZA | Peking Univ | PKU-CHN |
| Catholic Univ Portugal | UCP-PRT | Pennsylvania State Univ | PSU-USA |
| Catolica de Pelotas Univ | UCPEL-BRA | Pennsylvania Univ | UPenn-USA |
| Central Lancashire Univ | UCLan-GBR | Peoples Friendship Univ of Russia | RUDN-RUS |
| Central South Univ | CSU-CHN | Peradeniya Univ | UPeradeniya-LKA |
| CEU Cardenal Herrera Univ | CEU-UCH-ESP | Periyar Univ | PU-IND |
| Charles Darwin Univ | CDU-AUS | Perugia Univ | UNIPG-ITA |
| Charles R Drew Univ of Medicine & Science | CDU-USA | Philippines Manila Univ | UPM-PHL |
| Charles Univ | CU-CZE | Philippines Univ | UP-PHL |
| Chiang Mai Univ | CMU-THA | Philipps Univ of Marburg | Marburg Univ-DEU |
| Chicago Univ | UChicago-USA | Pittsburgh Univ | Pitt-USA |
| China Medical Univ | CMU-CHN | Pompeu Fabra Univ | UPF-ESP |
| Chongqing Medical Univ | CQMU-CHN | Ponce Health Sciences Univ | PHSU-USA |
| Chukwuemeka Odumegwu Ojukwu Univ | ANSU-NGA | Pontifícia Univ Catolica de Chile | UC Chile-CHL |
| Chulalongkorn Univ | CU-THA | Pontificia Univ Javeriana | PUJ-COL |
| Ciencias Aplicadas y Ambientales Univ | UDCA-COL | Port Harcourt Univ | UNIPORT-NGA |
| City Univ of New York | CUNY-USA | Porto Univ | UP-PRT |
| Clinical Centre of Serbia Univ | UKCS-SRB | Pretoria Univ | UP-ZAF |
| Colgate Univ | UColgate-USA | Princeton Univ | PU-USA |
| College Cork Univ | UCC-IRL | Purdue Univ | Purdue-System-USA |
| College of Surgeons of East, Central and Southern Africa | COSECSA-TZA | Pwani Univ | PU-KEN |
| Cologne Univ | UoC-DEU | Qassim Univ | QU-SAU |
| Colombo Univ | UoC-LKA | Qazvin Univ of Medical Sciences | QUMS-IRN |
| Colorado Univ | CU-System-USA | Qom Univ of Medical Science | Qom MS-IRN |
| Columbia Univ | CU-USA | Queens Univ | QU-CAN |
| Complutense de Madrid Univ | UCM-ESP | Queensland Univ | UQ-AUS |
| Constantine the Philosopher Univ in Nitra | UKF-SVK | Queensland Univ Technology | QUT-AUS |
| Contech School of Public Health | CSPH-PAK | Radboud Univ | RU-NLD |
| Copenhagen Univ | UCPH-DNK | Rajiv Gandhi Univ | RGU-IND |
| Cornell Univ | UC-USA | Rennes Univ | Rennes-FRA |
| Costa Rica Univ | UCR-CRI | Republic Univ | Udelar-URY |
| Curtin Univ | WAIT-AUS | Reykjavik Univ | RU-ISL |
| Dalarna Univ | DU-SWE | Rhode Island Univ | URI-USA |
| Dalhousie Univ | Dal-CAN | Rice Univ | UR-USA |
| Danube Univ Krems | UWK-AUT | Rochester Univ | URochester-USA |
| Dar es Salaam Univ | UDSM-TZA | Roma La Sapienza Univ | Sapienza-ITA |
| Dartmouth College | CDartmouth-USA | Ross Univ School of Medicine | RUSM-USA |
| Deakin Univ | DU-AUS | Rovira i Virgili Univ | URV-ESP |
| Debre Berhan Univ | DBU-ETH | Rush Univ | RU-USA |
| Debre Markos Univ | DMU-ETH | Rutgers Univ | RU-System-USA |
| Delhi Univ | DU-IND | Rwanda Univ | UR-RWA |
| Delta State Univ | DELSU-NGA | S Nijalingappa Medical College and HSK Hosp | NMCBGK-IND |
| Dessie Health Science College | DHSC-ETH | Saint James School of Medicine | SJSM-GBR |
| Development Studies Univ | UDS-GHA | Saint Joseph Univ | SJU-USA |
| Dhaka Univ | DU-BGD | Saint Louis Univ | SLU-USA |
| Diego Portales Univ | UDP-CHL | Saitama Medical Univ | SMU-JPN |
| Dilla Univ | DU-ETH | Salahaddin Univ-Erbil | SUE-IRQ |
| Dodoma Univ | UDOM-TZA | Salerno Univ | UNISA-ITA |
| Douala Univ | UDla-CMR | Samara Univ | SU-ETH |
| Drexel Univ | UD-USA | San Carlos de Guatemala Univ | USAC-GTM |
| Duke Kunshan Univ | DKU-CHN | San Carlos Univ | USC-PHL |
| Duke Univ | DU-USA | Sao Paulo Univ | USP-BRA |
| Duke-NUS Medical School | Duke-NUS-SGP | Saskatchewan Univ | uSask -CAN |
| Dundee Univ | UD-GBR | School of Medicine at Mount Sinai | ISMMS-USA |
| Durban Univ of Technology | DUT-ZAF | Science Univ of Malaysia | USM-MYS |
| Durham Univ | DU-GBR | Sciences de la Sante Univ | USS-GAB |
| Dusseldorf Univ | HHU-DEU | Seoul National Univ | SNU-KOR |
| Duy Tan Univ | DTU-VNM | Shahid Beheshti Univ of Medical Sciences | SBUMS-IRN |
| East Anglia Univ | UEA-GBR | Shahjalal Univ of Science and Technology | SUST-BGD |
| Eastern Finland Univ | UEF-FIN | Shandong Univ | SDU-CHN |
| Eastern Virginia Medical School | EVMS-USA | Shanghai Jiao Tong Univ | SJTU-CHN |
| Edinburgh Univ | EU-GBR | Sheffield Univ | TUOS-GBR |
| Edith Cowan Univ | ECU-AUS | Shenzhen Univ | SZU-CHN |
| Eduardo Mondlane Univ | UEM-MOZ | Sierra Leone Univ | USL-SLE |
| Egas Moniz School of Health and Science | ISCSEM-PRT | Simmons Univ | US-USA |
| Egerton Univ | EU-KEN | Simon Fraser Univ | SFU-CAN |
| Emory Univ | EU-USA | Sousse Univ | USO-TUN |
| Enugu State Univ of Science and Technology | ESUT-NGA | South Africa Univ | UNISA-ZAF |
| Erasmus Univ Rotterdam | EUR-NLD | South Alabama Univ | USA-USA |
| Estado Santa Catarina Univ | UDESC-BRA | South Australia Univ | UniSA-AUS |
| Estadual Campinas Univ | UNICAMP-BRA | South Carolina Univ | USC-System-USA |
| Ethiopian Defence Univ | EDU-ETH | Southampton Univ | US-GBR |
| Exeter Univ | UniofExter-GBR | Southern Denmark Univ | SDU-DNK |
| Extremadura Univ | UEX-ESP | Southern Univ College | Southern UC-MYS |
| Federal da Bahia Univ | UFBA-BRA | Split Univ | UNIST-HRV |
| Federal de Sao Paulo Univ | UNIFESP-BRA | Sri Ramachandra Univ | SRU-IND |
| Federal do Ceara Univ | UFC-BRA | St Andrews Univ | St Andrews-GBR |
| Federal Minas Gerais Univ | UFMG-BRA | St Augustine Univ of Tanzania | SAUT-TZA |
| Federal Rio Grande do Sul Univ | UFRGS-BRA | St Luke International Univ | LIU-JPN |
| Federal Santa Catarina Univ | UFSC-BRA | St Olaf College | StOlaf-USA |
| Federal Sergipe Univ | UFS-BRA | St. Lawrence College | SLC-CAN |
| Federal de Pelotas Univ | UFPel-BRA | St. Paul Hosp Millennium Medical College | SPHMMC-ETH |
| Felix Houphouet-Boigny Univ | UFHB-CIV | Stanford Univ | SU-USA |
| Ferhat Abbas Univ | UFAS-DZA | State Univ of Florida | SUSF -USA |
| Flinders Univ | FU-AUS | State Univ of New York | SUNY-USA |
| Florence Univ | UNIFI-ITA | State Univ of Semarang | UNNES-IDN |
| FOM Univ | FOM-DEU | State Univ of Zanzibar | SUZA-TZA |
| Fort Hare Univ | UFH-ZAF | Stavanger Univ | UiS-NOR |
| Francisco Marroquin Univ | UFM-GTM | Stellenbosch Univ | SU-ZAF |
| Freiburg Univ | Uni Freiburg-DEU | Stockholm Univ | SU-SWE |
| Fribourg Univ | UNIFR-CHE | Strasbourg Univ | UNISTRA-FRA |
| Friedrich Schiller de Jena Univ | Jena Univ-DEU | Suez Canal Univ | SCU-EGY |
| Fudan Univ | FDU-CHN | Sul de Santa Catarina Univ | UNISUL-BRA |
| Fujita Health Univ | FHU-JPN | Sun Yat Sen Univ | SYSU-CHN |
| Gadarif Univ | GU-SDN | Sungkyunkwan Univ | SKKU-KOR |
| Galway Univ | NUIG-IRL | Sydney Univ | USYD-AUS |
| Geneve Univ | UNIGE-CHE | Sylhet Medical Univ | SMU-BGD |
| George Mason Univ | GMU-USA | Taibah Univ | TaibahU-SAU |
| George Washington Univ | GWU-USA | Taif Univ | TU-SAU |
| Georgetown Univ | GU-USA | Taishan Medical Univ | TSU-CHN |
| Georgia Univ | UG-System-USA | Tamil Nadu Dr. M.G.R. Medical Univ | TNMGRMU-IND |
| Gezira Univ | UofG-SDN | Tampere Univ | TAU-FIN |
| Ghana Univ | UG-GHA | Tanta Univ | TU-EGY |
| Ghent Univ | UGent-BEL | Tartu Univ | UT-EST |
| Golestan Univ of Medical Sciences | GOUMS-IRN | Tasmania Univ | UTAS-AUS |
| Gondar Univ | UoG-ETH | Tbilisi State Medical Univ | TSMU-GEO |
| Gothenburg Univ | GU-SWE | Technology Sydney Univ | UTS-AUS |
| Griffith Univ | GU-AUS | Tehran Univ of Medical Sciences | TUMS-IRN |
| Groningen Univ | RUG-NLD | Tennessee Univ | UTennessee-System-USA |
| Guelph Univ | UofG-CAN | Texas Tech Univ | TTU-System-USA |
| Hacettepe Univ | HU-TUR | Texas Univ | UT-System-USA |
| Hail Univ | UOH-SAU | The College of New Jersey | TCNJ-USA |
| Hamadan Univ of Medical Sciences and Health Services | UMSHA-IRN | Thessaly Univ | UTH-GRC |
| Hamdan Bin Mohammed Smart Univ | HBMSU-ARE | Thomas Jefferson Univ | TJU-USA |
| Hanoi Medical Univ | HMU-VNM | Tokyo Univ | Utokyo-JPN |
| Haramaya Univ | HU-ETH | Tor Vergata Univ of Rome | Tor Vergata-ITA |
| Harvard Univ | HU-USA | Toronto Univ | UToronto-CAN |
| Hasselt Univ | Uhasselt-BEL | Touro Univ System | Touro-System-USA |
| Hawaii Univ | UH-System-USA | Tribhuvan Univ | TU-NPL |
| Health Sciences Univ | UHS Lahore | Trieste Univ | UniTS-ITA |
| Health Sciences Univ | UHS Lahore-PAK | Tripoli Univ | UOT-LBY |
| Hebrew Univ of Jerusalem | HUJI-ISR | Trnava Univ | TU-SVK |
| Heidelberg Univ | Uni Heidelberg-DEU | Tromso Univ | UiT-NOR |
| Helsinki Univ | UH-FIN | Tubingen Univ | Uni Tubingen-DEU |
| Helwan Univ | HU-EGY | Tufts Univ | UT-USA |
| Higher National Veterinary School | ENSV-DZA | Tulane Univ | TU-USA |
| Hohenheim Univ | Uni Hohenheim-DEU | Tumaini Univ Makumira | TUMa-TZA |
| Hong Kong Polytechnic Univ | PolyU-CHN | Tunis El Manar Univ | UTM-TUN |
| Hong Kong Univ | HKU-CHN | Turin Univ | UniTo-ITA |
| Howard Univ | UHoward-USA | Tyrolean Private Univ | UMIT TIROL-AUT |
| Huazhong Univ of Science and Technology | HUST-CHN | Uganda Christian Univ | UCU-UGA |
| Hue Univ | HU-VNM | Ulm Univ | Ulm-DEU |
| Ibadan Univ | UI-NGA | Umea Univ | UMU-SWE |
| Idaho Univ | UIdaho-USA | Umm Al-Qura Univ | UQU-SAU |
| Illinois Univ | UI-System-USA | Union Univ | UU-USA |
| Ilorin Univ | UNILORIN-NGA | United Arab Emirates Univ | UAEU-ARE |
| Imperial College London | UImperial-GBR | Univ Internacional de Catalunya | UIC-ESP |
| Indiana Univ | IU-System-USA | Univ Medical Group | UMG-USA |
| Indonesia Univ | UI-IDN | Univ of Health and Allied Sciences | UHAS-GHA |
| International Medical Univ | IMU-MYS | Univ of Medicine and Dentistry of New Jersey | UMDNJ-USA |
| Iowa Univ | UIowa-USA | Univ of Medicine Tirana | UMT-ALB |
| Iran Univ of Medical Sciences | IUMS-AUS | Univ of Pittsburgh Medical Center | UPMC-USA |
| Iran Univ of Medical Sciences | IUMS-IRN | Univ of the East Ramon Magsaysay Memorial Medical Center | UERMMMC-PHL |
| ISHIK Univ | ISHIK Univ-IRQ | Univ Research Co LLC | URC-USA |
| Jackson State Univ | JSU-USA | Univ System of Georgia | USG-USA |
| Jagiellonian Univ | JU-POL | Univ System of Maryland | NIAID-USA |
| James Cook Univ | JCU-AUS | Univ System of Maryland | USM-System-USA |
| Jazan Univ | JazanU-SAU | Univ System of Ohio | UO-System-USA |
| Jean Lorougnon Guede Univ | UJLG-CIV | Uppsala Univ | UU-SWE |
| Jichi Medical Univ | JMU-JPN | Usmanu Danfodiyo Univ | UDUS-NGA |
| Jilin Univ | JLU-CHN | Utkal Univ | UU-IND |
| Jimma Univ | JU-ETH | Utrecht Univ | UU-NLD |
| Jinan Univ | JNU-CHN | Valencia Univ | UV-ESP |
| Johns Hopkins Univ | JHU-USA | Vanderbilt Univ | Vandy-USA |
| Jomo Kenyatta Univ of Agriculture and Technology | JKUAT-KEN | Venda Univ | UNIVEN-ZAF |
| Jordan Univ of Science and Technology | JUST-JOR | Versailles – Saint-Quentin-en-Yvelines Univ | UVSQ-FRA |
| Jos Univ | UNIJOS-NGA | Victoria Univ | VU-CAN |
| Jouf Univ | JU-SAU | Vilnius Univ | VU-LTU |
| Julius Maximilian Univ of Wurzburg | JMU-DEU | Virginia Commonwealth Univ | VCU-USA |
| Justus Liebig Univ Giessen | JLU-DEU | Virginia Polytechnic Institute and State Univ | Virginia Tech-USA |
| Kansas Univ | KU-USA | Virginia Univ | UVA-USA |
| Karabuk Univ | KBU-TUR | Vrije Univ Amsterdam | VU Amsterdam-NLD |
| Karolinska Institute | KI-SWE | Wageningen Univ & Research | WUR-NLD |
| Kassala Univ | KU-SDN | Wake Forest Univ | WFU-USA |
| Kathmandu Univ | KU-NPL | Walden Univ | WaldenU-USA |
| Katholieke Univ Leuven | KU Leuven-BEL | Warwick Univ | UW-GBR |
| Kazakh National Medical Univ | KazNMU-KAZ | Washington Kenya Univ | UW-KEN |
| Kentucky Univ | UKY-USA | Washington State Univ | WSU-System -USA |
| Kenyatta Univ | KU-KEN | Washington Univ | UW-USA |
| Kerman Univ of Medical Sciences | KMU-IRN | Washington Univ in St Louis | WUSTL-USA |
| Kermanshah Univ of Medical Sciences | KUMS-IRN | Wayne State Univ | WSU-USA |
| Khartoum Univ | UofK-SDN | Weill Cornell Medical College | WCM-Q-QAT |
| Khon Kaen Univ | KKU-THA | Wenzhou Medical Univ | WMU-CHN |
| King Abdulaziz Univ | KAU-SAU | West Indies Univ | UWI-JAM |
| King George Medical Univ | KGMU-IND | West of England Univ | UWE-GBR |
| King Saud bin Abdulaziz Univ for Health Sciences | KSAU-HS-SAU | West Virginia Univ | WVU System-USA |
| King Saud Univ | KSU-SAU | Western Australia Univ | UWA-AUS |
| Kinshasa Univ | UNIKIN-ZAR | Western Cape Univ | UWC-ZAF |
| KLE Univ | KLE Univ-IND | Western Kentucky Univ | WKU-USA |
| Koc Univ | KU-TUR | Western Ontario Univ | UWO-CAN |
| Korea Univ | KU-KOR | Western Sydney Univ | UWS-AUS |
| Kosin Univ | UK-KOR | Wisconsin Univ | UW System-USA |
| Kragujevac Univ | UK-SRB | Witwatersrand Univ | Wits Univ-ZAF |
| Kurdistan Univ of Medical Sciences | MUK-IRN | Wolaita Sodo Univ | WSU-ETH |
| Kwame Nkrumah Univ of Science and Technology | KNUST-GHA | Wollega Univ | WU-ETH |
| KwaZulu-Natal Univ | UKZN-ZAF | Wollongong Univ | UOW-AUS |
| Kyoto Univ | Kyoto U-JPN | Women College Research Institute | WCRI-CAN |
| Kyung Hee Univ | KHU-KOR | Wrocław Medical Univ | WMU-POL |
| La Trobe Univ | LaTrobeU-AUS | Xi an Jiaotong Univ | XJTU-CHN |
| Ladoke Akintola Univ of Technology | LAUTECH-NGA | Xiamen Univ | XMU-MYS |
| Lagos State Univ | LASU-NGA | Yale Univ | YU-USA |
| Lagos Univ | UNILAG-NGA | Yaounde I Univ | UYI-CMR |
| Lahore College for Women Univ | LCWU-PAK | Yokohama City Univ | YCU-JPN |
| Lancaster Univ | ULancaster-GBR | Yonsei Univ | YU-KOR |
| Latvia Univ | UL-LVA | York Univ | York Univ-CAN |
| Lausanne Univ | UNIL-CHE | York Univ | York Univ-GBR |
| Leeds Univ | ULeeds-GBR | Zagazig Univ | ZU-EGY |
| Leicester Univ | UL-GBR | Zahedan Univ Medical Sciences | ZUMS-IRN |
| Leiden Univ | LEI-NLD | Zambia Univ | UNZA-ZMB |
| Libre Bruxelles Univ | ULB-BEL | Zayed Univ | ZU-ARE |
| Libyan International Medical Univ | LIMU-LBY | Zhejiang Univ | ZJU-CHN |
| Limoges Univ | UNILIM-FRA | Ziekenhuis Brussel Univ | UZ Brussel-BEL |
| Lincoln Univ | LU-GBR | Zimbabwe Univ | UZ-ZWE |
| Lisbon Univ | ULisboa-PRT | Zurich Univ | UZH-CHE |
| Lithuanian Univ of Health Sciences | LSMU-LTU |
References
- Atal, I.; Trinquart, L.; Ravaud, P.; Porcher, R. A mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non high-income regions. Journal of Clinical Epidemiology 2018, 98, 123–132. [Google Scholar] [CrossRef] [PubMed]
- Cerdeira, J.; Mesquita, J.; Vieira, E.S. International research collaboration: Is Africa different? A cross-country panel data analysis. Scientometrics 2023, 128(4), 2145–2174. [Google Scholar] [CrossRef]
- Cherven, K. Mastering Gephi network visualization: Produce advanced network graphs in Gephi and gain valuable insights into your network datasets; Packt Publishing: Birmingham, UK, 2015. [Google Scholar]
- Clarivate. InCites Indicators Handbook. 2021. Available online: https://incites.help.clarivate.com/Content/Indicators-Handbook/ih-about.htm.
- Confraria, H.; Wang, L. Medical research versus disease burden in Africa. Research Policy 2020, 49(3). [Google Scholar] [CrossRef]
- Evans, J.A.; Shim, J.M.; Ioannidis, J.P.A. Attention to Local Health Burden and the Global Disparity of Health Research. PLoS ONE 2014, 9(4). [Google Scholar] [CrossRef] [PubMed]
- Liu, L.; Johnson, H.L.; Cousens, S.; Perin, J.; Scott, S.; Lawn, J.E.; Rudan, I.; Campbell, H.; Cibulskis, R.; Li, M.; et al. Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet 2012, 379(9832), 2151–2161. [Google Scholar] [CrossRef] [PubMed]
- Mouton, J.; Blanckenberg, J. African science: A bibliometric analysis. In The Next Generation of Scientists in Africa; Beaudry, C., Mouton, J., Prozesky, H., Eds.; African Minds: Cape Town, South Africa, 2018. [Google Scholar]
- Newman, M.E.J. Clustering and preferential attachment in growing networks. Physical Review E 2001, 64(2). [Google Scholar] [CrossRef] [PubMed]
- Nieuwoudt, L.; Mackay, C.A.; Mda, S. Causes of and Modifiable Factors Contributing to Neonatal Deaths at Dora Nginza Hospital in the Eastern Cape, South Africa. Global Pediatric Health 2022, 9. [Google Scholar] [CrossRef] [PubMed]
- Ou, Z.; Yu, D.; Liang, Y.; He, H.; He, W.; Li, Y.; Zhang, M.; Gao, Y.; Wu, F.; Chen, Q. Global trends in incidence and death of neonatal disorders and its specific causes in 204 countries/territories during 1990–2019. Bmc Public Health 2022, 22(1). [Google Scholar] [CrossRef] [PubMed]
- Owusu-Nimo, F.; Boshoff, N. Research collaboration in Ghana: Patterns, motives and roles. Scientometrics 2017, 110(3), 1099–1121. [Google Scholar] [CrossRef]
- Potter, I. Introducing Citation Topics in InCites. 2020. Available online: https://clarivate.com/blog/introducing-citation-topics/.
- Sooryamoorthy, R. Science in Africa: Contemporary Trends in Research. Journal of Scientometric Research 2021, 10(3), 366–372. [Google Scholar] [CrossRef]
- Stefanoudis, P.V.; Licuanan, W.Y.; Morrison, T.H.; Talma, S.; Veitayaki, J.; Woodall, L.C. Turning the tide of parachute science. Current Biology 2021, 31(4), R184–R185. [Google Scholar] [CrossRef] [PubMed]
- UN. The Sustainable Development Goals Report. 2022. Available online: https://unstats.un.org/sdgs/report/2022/The-Sustainable-Development-Goals-Report-2022.pdf.
- UN. Newborn mortality. 2024. Available online: https://www.who.int/news-room/fact-sheets/detail/newborn-mortality.
- Vieira, E.S. The influence of research collaboration on citation impact: The countries in the European Innovation Scoreboard. Scientometrics 2023, 128(6), 3555–3579. [Google Scholar] [CrossRef]
- Vieira, E.S.; Cerdeira, J. The integration of African countries in international research networks. Scientometrics 2022, 127(4), 1995–2021. [Google Scholar] [CrossRef]
- Vieira, E.S.; Gomes, J. Citations to scientific articles: Its distribution and dependence on the article features. Journal of Informetrics 2010, 4(1), 1–13. [Google Scholar] [CrossRef]
- Waltman, L. A review of the literature on citation impact indicators. Journal of Informetrics 2016, 10(2), 365–391. [Google Scholar] [CrossRef]
- Wang, H.; A Liddell, C.; Coates, M.M.; Mooney, M.D.; E Levitz, C.; E Schumacher, A.; Apfel, H.; Iannarone, M.; Phillips, B.; Lofgren, K.T.; et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014, 384(9947), 957–979. [Google Scholar] [CrossRef] [PubMed]
- WHO. A heavy burden: The productivity cost of illness in Africa. 2019.
Figure 1.
The total number of articles on NC research in Africa. For the graph on the left, the trendline is as follows (r-square=0.9831).
Figure 1.
The total number of articles on NC research in Africa. For the graph on the left, the trendline is as follows (r-square=0.9831).

Figure 2.
Evolution of the CNCI of NC research. The number of articles is below 20 between 2000 and 2007 (each year). For these years, the results are shown for information purposes and not for discussion.
Figure 2.
Evolution of the CNCI of NC research. The number of articles is below 20 between 2000 and 2007 (each year). For these years, the results are shown for information purposes and not for discussion.

Figure 3.
Distribution of articles by topic. Only the top 5 topics, according to the number of articles, are shown.
Figure 3.
Distribution of articles by topic. Only the top 5 topics, according to the number of articles, are shown.

Figure 4.
Evolution of DRC, IRC and articles without collaboration (no_coll). For IRC and DRC curves, the trendlines are as follows: IRC- (r-square = 0.9622); DRC-(r-square = 0.9448).
Figure 4.
Evolution of DRC, IRC and articles without collaboration (no_coll). For IRC and DRC curves, the trendlines are as follows: IRC- (r-square = 0.9622); DRC-(r-square = 0.9448).

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.